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“Flying is learning how to throw yourself at the ground and miss.” 
 
Douglas Adams  
  
Abstract 
 
Bjerketorp, J. 2004. Novel Adhesive Proteins of Pathogenic Staphylococci and Their 
Interaction with Host Proteins. Doctor’s dissertation. 
ISSN 1401-6249, ISBN 91-576-6463-3. 
 
In this thesis, interactions between bacterial and host proteins have been studied by a phage 
display approach. Affinity selection of a Staphylococcus aureus shotgun phage display 
library against human von Willebrand factor (vWf), led to the identification of a novel 
secreted vWf-binding protein (vWbp). Mature vWbp, which consists of 482 amino acids, 
could be recovered from an S. aureus culture supernatant. The specific interaction between 
vWbp and vWf is mediated by a region of 26 amino acids located in the C-terminal part of 
vWbp. Further characterisation revealed vWbp to be a bifunctional protein capable of 
inducing coagulation of plasma from several species, but with preference for human and 
porcine plasma. The coagulating activity was found to reside in the N-terminal part of 
vWbp, and to be depended on the interaction with prothrombin. Similarly, panning a 
Staphylococcus lugdunensis phage display library against human vWf resulted in the 
recognition of a novel vWf-binding protein (vWbl). This protein comprises 2060 amino 
acids, including a cell wall sorting signal with a surface-anchoring LPXTG-motif. The 
vWf-binding part of vWbl is located in repetitive domains. The incidence of the genes 
encoding vWbp and vWbl is very high in clinical isolates of the respective staphylococcal 
species. 
In addition, the S. aureus library was sorted against ex vivo biomaterial, and six different 
staphylococcal protein were identified: coagulase, Efb, protein A, FnbpA, FnbpB, and Sbi. 
Fibrinogen-binding and β2-glycoprotein I (β2-GPI)-binding phagemid particles were 
dominating. Proteins adsorbed to different ex vivo central venous catheters were 
investigated using specific antibodies. Fibrinogen was found to be most abundant, but 
β2-GPI was also detected on the investigated biomaterials. This is noteworthy in view of 
S. aureus adherence to biomaterials, but might also implicate a source for induction of 
disease-causing β2-GPI-autoantibodies.  
vWf is an essential molecule for platelet adherence and aggregation, especially during 
rapid blood flow. Thus, it is intriguing that two virulent staphylococcal species, both 
capable of causing life threatening endocarditis, have evolved proteins with affinity for 
vWf. Perhaps even more intriguing, both vWbp and vWbl presumably bind the same site 
in  vWf, as indicated by cross-inhibition studies. However, the exact role for these 
staphylococcal proteins concerning staphylococcal pathogenesis remains to be elucidated. 
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Abbreviations 
 
Aap        Accumulation-associated  protein 
agr       Accessory  gene  regulator   
APC       Antigen-presenting  cell   
β2- G P I       β2-glycoprotein I  
Bap        Biofilm-associated  protein 
Bbp        Bone  sialoprotein-binding  protein 
CHIPS      Chemotaxis  inhibitory  protein  of  S. aureus  
ClfA/B      Clumping  factor  A/B 
Cna        Collagen-binding  protein 
CoNS       Coagulase-negative  staphylococci 
CVC       Central  venous  catheter 
ECM       Extracellular  matrix 
Ebh        ECM-binding  protein  homologue  (S. aureus, ORF 31,5 kb) 
Efb        Extracellular  fibrinogen-binding  protein 
Emp      ECM  protein-binding  protein  (S. aureus, ORF 1,0 kb) 
Embp       ECM-binding  protein  (S. epidermidis, ORF 30,5 kb) 
ET        Exfoliative  toxin 
E-tag       Expression  screening  tag 
FAME        Fatty  acid-modifying  enzyme 
Fbe        Fibrinogen-binding  protein  from  S. epidermidis 
FnbpA/B     Fibronectin-binding  protein  A/B 
ICAM-1    Intercellular  adhesion  molecule-1   
MHC       Major  histocompability  complex 
MRSA      Methicillin-resistant  S. aureus 
ORF  Open reading frame 
Pls Plasmin-sensitive  protein 
S A G        S u p e r a n t i g e n  
SAK       Staphylokinase 
S a s G        S. aureus surface protein G  
S b i         S. aureus IgG-binding protein 
S D R        S D - r e p e a t s  
SE        Staphylococcal  enterotoxin   
SSSS       Staphylococcal  scalded  skin  syndrome 
TSS      Toxic  shock  syndrome 
TSST-1      Toxic  shock  syndrome  toxin-1   
VISA       Vancomycin-intermediate-resistant  S. aureus 
VRE       Vancomycin-resistant  enterococci 
V R S A      V a n c o m y c i n - r e s i s t a n t   S. aureus 
vWbp       von  Willebrand  factor-binding protein  
vWbl  von Willebrand factor-binding protein from S. lugdunensis 
vWf      von  Willebrand  factor  
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Introduction 
 
“When you take stuff from one writer it’s plagiarism; 
but when you take it from many writers, it’s research.”  
Wilson Mizner  
 
General background 
Of all living organisms, microbes are the most diverse products of evolution. Life 
itself stems from these microscopic beings, and together bacteria constitute the 
majority of all life. They have adapted to environments as diverse as boiling wells, 
ice and snow, the Dead Sea, bare rock, airborne particles, and upon or within 
living creatures. The norm is that you find bacteria wherever on earth you look. 
Consequently, bacteria exhibit an outstanding range of metabolic capabilities, but 
more than 99% of the existing bacterial species are still not possible to cultivate.  
 
Even though the full range of bacterial species remains unknown, many are 
intimately involved in health and disease of humans and animals. The human body 
is colonised by bacteria at an approximate ratio of ten bacteria per human cell. 
Most are commensals, which benefit from living associated with us without 
causing harm. They might even protect us from disease by competing for nutrients 
with pathogenic bacteria. Disease-causing bacteria can be obligate pathogens, 
always causing disease, or opportunistic pathogens. The latter are normally 
commensals until some factor in the host-bacteria relationship changes, like 
malnutrition of the host, or if the bacteria enter an erroneous location in the host.  
 
At the beginning of the last century, infectious diseases were the leading cause 
of death worldwide. However, this all changed due to better standards of living, 
the accidental discovery of penicillin by Fleming, and the many more antibiotics 
that  followed. The development and use of antibiotics greatly reduced the death 
toll by bacterial diseases. A few decades ago, the battle against bacterial infections 
was generally believed to be won. However, the adaptive bacteria responded to the 
increased selective pressure introduced by the use and over-use of antibiotics. The 
microbes started to develop resistance against many antibiotics, and once more, 
bacterial infections emerged as a severe threat on the global scene. Some examples 
of important human bacterial pathogens are species of Bacillus,  Borrelia, 
Campylobacter,  Clostridium,  Enterococcus,  Escherichia,  Haemophilus, 
Helicobacter, Legionella, Mycobacterium, Neisseria, Salmonella, Staphylococcus, 
Streptococcus, Vibrio and Yersinia, of which several show increasing resistance 
against many commonly used antibiotics. 
 
The genus Staphylococcus 
The focus of this thesis is on Staphylococcus aureus, the key member of the genus 
Staphylococcus with regard to human disease. Also, the more infrequently 
encountered opportunistic pathogen S. lugdunensis, and some other staphylococci   10
are discussed to some extent when considered appropriate. Staphylococci are 
Gram-positive,  i.e. protected by a thick cell wall, composed of layers of 
peptidoglycan and additional teichoic, and lipoteichoic acid. They are coccoid, i.e. 
spherical in shape, and with a diameter of 0,5-1,5 µm, non-motile, non-
sporulating, facultativly anaerobic, catalase-positive, highly salt- and lipid-
tolerant, and their DNA contains 30 to 40% of guanine and cytosine residues. 
Staphylococci divide in more than one plane and are found as single cells, in pairs, 
tetrads, short chains, grape-like irregular clusters, or in a biofilm. Staphylococci 
were seen in human pus by Koch 1878, cultured by Pasteur 1880 and subsequently 
named by the Scottish surgeon Ogston. Staphyle denotes a bunch of grapes in 
Greek. They were formally described as S. aureus and S. albus by Rosenbach in 
1884, based on the golden and white colour of the colonies, respectively. Since 
then,  S. albus has been renamed to S. epidermidis, and today 36 species of 
staphylococci are recognised (Götz, Bannerman & Schleifer, 2004).  
 
The genus is divided into coagulase-positive and coagulase-negative 
staphylococci (CoNS). This division is based on the occurrence of coagulase, or 
staphylocoagulase, an extracellular protein that has the ability to cause blood and 
plasma from various animals to clot. Only a few staphylococcal species are 
coagulase-positive and in clinical practise, coagulase-positive equals S. aureus, 
since this is the only coagulase-positive species colonising humans. Further, 
S. aureus is considered the most virulent of the staphylococci, and consequently 
the main pathogen. All members of the large and heterogeneous group of CoNS 
are in general significantly less virulent than S. aureus. Some CoNS, noted as 
important human pathogens, are still fairly virulent, e.g.  S. lugdunensis and 
S. epidermidis (Lambe et al., 1990). Staphylococci are normally found on skin and 
mucous membranes of mammals and birds. S. aureus is found in the nose of more 
than 30% of the healthy human population and S. epidermidis is found on the skin 
of all humans. The natural habitat of S. lugdunensis appears to be in the inguinal 
area of humans (van der Mee-Marquet et al., 2003). At least 14 staphylococcal 
species are known to colonise man in different frequencies (Kloos & Bannerman, 
1994). They are spread in hospitals and communities by direct contact, but also by 
indirect contact, due to the ability of staphylococci to survive for long periods in 
the relatively dry environment outside the host. 
 
Staphylococci and disease 
The infection process 
Newly transmitted staphylococci have to adhere to the cells of the new host in 
order to colonise. If then an infection is to take place, the next task for the 
staphylococci is to pass the physical barriers of the host. The most frequent portals 
of entry are the sites where the comparatively dry, acidic and impermeable skin 
meets the moist and soft mucous membranes. Whenever the barriers are in any 
way injured, as during surgery, excellent entry sites are provided. Inside the body 
the staphylococci can once again attach to a suitable surface and establish a 
primary site of infection. As long as the staphylococci can evade the host immune 
system, they will multiply and spread, either directly through tissues, or via the   11
lymphatic system to the bloodstream causing septicemia. Staphylococci are now 
able to reach remote sites and cause a variety of clinical manifestations and 
diseases. The typical pathological finding of staphylococcal infections due to S. 
aureus is abscess formation. Patients with S. aureus septicemia are rarely cured 
unless the abscesses are drained. It is noteworthy that before the antibiotic era, the 
typical patient with S. aureus septicemia was young, previously healthy, had 
developed the infection from a superficial skin lesion, and died in more than 80% 
of the cases (Sjursen, 1999).  
 
Staphylococcus aureus 
S. aureus causes a broad range of diseases in humans, ranging from superficial 
skin infections, e.g. impetigo, to life threatening deep-seated infections, e.g. 
endocarditis (Lowy, 1998). Other examples, where S. aureus stands out as a 
serious pathogen, are soft-tissue, respiratory, bone, and joint infections, and in 
fact, S. aureus infections can involve any organ system. The wide variety of 
diseases caused by S. aureus is a result of its extensive spectrum of virulence 
factors, discussed in more detail later in this thesis. Several diseases caused by S. 
aureus involve toxin production, including impetigo and the much more severe 
form of disseminated skin disease named staphylococcal scalded skin syndrome 
(SSSS), as well as toxic shock syndrome (TSS) and food poisoning. 
 
Staphylococcus lugdunensis and other CoNS 
As highlighted in several case reports, S. lugdunensis infections are not very 
common, but can be aggressive in its nature and possibly, this is the 
staphylococcal species that comes closest to S. aureus with regard to virulence 
(Etienne et al., 1989). S. lugdunensis has been reported to cause endocarditis, 
biomaterial-associated infections, septic arthritis, meningitis, and wound infections 
(Fleurette et al., 1989; Kaabia et al., 2002). Still, little is known why this species 
has the potential to cause more aggressive infections than other CoNS. S. schleiferi 
also seems to share some resemblance to S. lugdunensis and S. aureus concerning 
virulence. However, when it comes to the more numerous foreign body infections, 
S. epidermidis is the primary pathogen. Other important causative agents of 
infections in conjunction with indwelling medical devices are S. aureus and the 
CoNS as a group, quite often represented by S. haemolyticus,  S. capitis, 
S. hominis, or S. warneri (Kloos & Bannerman, 1994). 
 
Pathogens of medical progress 
The number of staphylococcal infections has increased noticeably over the past 
decades. In part, this increase is due to an improved inclination to report cultures 
of CoNS as true pathogens, but in addition, a factual increase of the infection 
incidence is generally recognised. S. aureus and CoNS, have been reported as the 
most common pathogens of nosocomial, or hospital-acquired, infections, if urinary 
tracts infections are excluded (Emori & Gaynes, 1993). This is even more marked 
among the reported nosocomial bacteremias caused predominantly by CoNS, but 
also frequently by S. aureus, as noted in a recent review (von Eiff, Peters &   12
Heilmann, 2002). This trend parallels the increased use of intravascular devices, 
and there are reports that more than half of the S. aureus bacteremias are 
associated with such devices (Steinberg, Clark & Hackman, 1996).  
 
Modern medical practice continues to employ a rising number of artificial 
devices, both for permanent and more temporary use, e.g. artificial heart valves 
and central venous catheters, respectively. When a foreign material is implanted in 
the body, it interacts with the surrounding tissue and body fluids, and the surface 
of the implant is rapidly covered with different blood proteins. This adsorption 
depends in part on the physiochemical nature of the implanted material, and much 
effort has been spent on improving the inherent characteristics of biomaterials 
with regard to, e.g. tissue compatibility. The process of coating is dynamic, and 
the composition of adhered proteins will change over time, when the initially 
adsorbed proteins are replaced, or covered by other proteins (Courtney et al., 
1994; Vroman et al., 1980). The adsorbed proteins can cause different problems 
such as activation of the coagulation system, and inflammation. Further, the 
insertion site is easily contaminated with staphylococci, and the coated biomaterial 
will promote their adherence. Once adhered, staphylococci readily colonise the 
biomaterial and establish an infection, which is difficult to cure, due to the 
formation of bacterial communities known as biofilm (von Eiff, Peters & 
Heilmann, 2002). This consists of multiple layers of bacteria that have embedded 
themselves in slime, i.e. a hydrated matrix made of extracellular polysaccharides 
and proteins. Biofilms attract a lot of interest since most bacteria probably live in 
biofilms on different suitable surfaces, which apparently include implanted 
medical devices (Schachter, 2003). The removal of the implant on which a biofilm 
has formed is usually required in order to cure this otherwise highly persistent 
form of infection. The ever-increasing use of biomaterials in modern medicine has 
given staphylococci in general, and CoNS in particular, the opportunity to step 
forward as the pathogens of medical progress (Rupp & Archer, 1994).  
 
Antibiotic resistance 
Another aspect of modern medicine is the use of antibiotics to combat bacterial 
infections. However, due to abuse of this miracle drug, the effectiveness of 
antibiotic treatment is waning. In clinical practice, most often the causative agent 
of an infection is not determined, instead broad-range antibiotics are used. Also, 
too often antibiotics are wasted on common colds caused by viral infections, 
which are not affected by antibiotics. Further, huge amounts of antibiotics are 
given as a growth enhancer in the feed of farm animals, enormous amounts of 
antibiotics are applied in agriculture as pesticides, and hundreds of everyday 
household products now contain antibacterial agents (Levy, 2001). Besides, many 
antimicrobial substances are intrinsically stable, and are found in the environment 
long after the actual antibiotic treatment. This massive onslaught of antibacterial 
compounds exerts a strong selection pressure on the resourceful microorganisms. 
The selection pressure is ingeniously met by the spread of existing resistance 
determinants, and the development of new ones.  
 
The bacterial genomes are by no means fixed entities. A bacterium has the   
potential to quickly multiply, in an optimal environment in as short time as 20   13
minutes, and coupled to this short generation time is the possibility to mutate. 
Further, a bacterium has the ability to acquire foreign DNA elements with useful 
resistance genes in numerous ways, via conjugative plasmids, transposons, 
bacteriophages, or as naked DNA, directly from the surroundings. Many of these 
mobile elements, like the broad host range plasmids, have the capacity to move 
freely, not only between bacteria of the same species, but also between different 
species and genera. Besides, several resistance determinants are often occurring 
together on mobile elements, and this certainly facilitates the widespread 
distribution of multiple resistance genes among bacteria (Rice, 2000). 
  
The current situation for nosocomial staphylococcal infections in some parts of 
the world, e.g. USA is that close to 60% of S. aureus isolates are resistant to 
methicillin (MRSA) (Anonymous, 2003). The corresponding figure for CoNS is 
close to 90%. Due to their nosocomial origin, the isolated staphylococci often 
carry resistance determinants against several important antibiotics. Vancomycin 
has for decades been the most important drug against these infections. However, 
vancomycin resistance appeared many years ago in some CoNS (Schwalbe, 
Stapleton & Gilligan, 1987). MRSA with heterogeneous or intermediate 
vancomycin resistance (VISA) also started to emerge some years ago (Hiramatsu 
et al., 1997). Further, resistance to vancomycin is often found in clinical isolates 
of enterococci (VRE), and the transfer of the gene, vanA, encoding the 
vancomycin resistance determinant, to S. aureus has been observed in the 
laboratory (Noble, Virani & Cree, 1992). In 2002, the long anticipated reports 
appeared, describing the first cases of clinical isolates of S. aureus resistant to 
vancomycin (VRSA) (Anonymous, 2002a, b). For a relatively long time, no new 
types of antimicrobial compounds have been developed, with the exception of 
oxazolidinone, which is a novel type of protein synthesis inhibitor with activity 
against Gram-positive bacteria (Diekema & Jones, 2001). Some cases of resistance 
to linezolid has already been reported, both in VRE and in MRSA (Tsiodras et al., 
2001). If also these resistance determinants against vancomycin and linezolid 
become widespread among the hospital isolates on a global scale, the future 
situation for treatment of the nosocomial staphylococcal infections is grave.  
 
Another clinically important aspect of bacterial resistance is the fact that bacteria 
in biofilms, e.g. on an indwelling medical device, are intrinsically less susceptible 
to antibiotics (Donlan, 2001). Microbes in a biofilm are 10 to 1000-fold less 
sensitive than planktonic, or free-floating, microbes, with regard to the same 
antimicrobial agent. As an example, in order to kill biofilm-living cells of S. 
aureus with chlorine, an oxidizing biocide considered as one of the most efficient 
antibacterial agents, a 600-fold higher dose is needed, compared to the dose that 
kills planktonic S. aureus (Luppens et al., 2002). One explanation to biofilm 
resistance could be the adsorption of some antibiotics due to charge interactions 
with the biofilm-matrix, which might result in a slow or incomplete penetration of 
the antibiotics into the deeper layers of the biofilm (Stewart & Costerton, 2001). 
Another hypothesis focuses on the altered microenvironment within the biofilm, 
where the more actively growing and antibiotic-susceptible surface bacteria of the 
biofilm-community consume most of the nutrients available. This renders the 
deeper parts of the biofilm, where waste products might accumulate, more acidic 
and anaerobic. On the whole these deeper located biofilm dwellers are dormant   14
and non-growing, and as a result, less susceptible to antibiotics compared to the 
surface bacteria. An additional theory is the existence of a unique, and highly 
protected biofilm phenotype, where a sub-population of biofilm microbes express 
biofilm-specific genes, that induce changes in the morphology and biochemistry of 
these bacteria compared to planktonic bacteria (Costerton, Stewart & Greenberg, 
1999; Davies, 2003). The observed phenomenon of biofilm resistance is likely to 
be of complex nature, and stems probably from a combination of some of the 
mechanisms proposed, and others, still to be found. 
 
Antibiotic resistance that is caused by acquired resistance genes, is best escaped 
by removing the selective pressure promoting this carriage, an objective that will 
only be achieved through prudent use of antimicrobial substances. An alternative 
route to combat antibiotic resistance is the search for novel compounds that act 
upon the bacteria, preferably both in the planktonic and biofilm state, and without 
selecting for resistance, a task yet to be accomplished. Also a vaccine would be 
active against antibiotic-resistant bacteria, and a vaccine that targets 
staphylococcal adherence might also prevent the problem of biofilm formation, but 
the vaccine approach have so far proved difficult with regard to staphylococci. 
 
Virulence factors 
Capsule 
The capsular polysaccharides are important surface components, forming a 
glycocalyx. It has been reported that more than 90% of S. aureus isolates produce 
one of 11 serologically distinct capsular polysaccharides (Sompolinsky et al., 
1985). The most common capsule types among clinical isolates of S. aureus, are 
the serotypes 8 and 5, found in 50% and 25% of the isolates, respectively. The 
presence of a capsule is thought to enhance staphylococcal virulence by impairing 
phagocytosis. Capsules have been shown to modulate adherence of S. aureus to 
endothelial cells in vitro, and to promote colonisation and persistence on mucosal 
surfaces in vivo (O'Riordan & Lee, 2004).  
 
Peptidoglycan 
The major cell wall component of S. aureus, peptidoglycan, is known to cause 
proinflammatory responses and platelet aggregation in the host, ultimately leading 
to disseminated intravascular coagulation in cases of severe septicemia (Kessler, 
Nussbaum & Tuazon, 1991). Peptidoglycan has also been reported to induce tissue 
factor expression in monocytes, and thereby activate the coagulation cascade, 
which will be discussed in more detail later in this thesis (Mattsson et al., 2002).  
 
Lysylphosphatidylglycerol 
The most common bacterial membrane phospholipids, phosphatidylglycerol and 
diphosphatidylglycerol, are negatively charged. This makes bacteria susceptible to 
cationic antimicrobial peptides of the host defence, discussed later on in this 
thesis. However, some pathogens like S. aureus can modify their phospholipids by 
attaching positively charged lysine residue. This results in lysylphosphatidyl-  15
glycerol, which repels the cationic peptides and thus, can confer resistance to 
S. aureus. The gene product responsible for this modification of phospholipids is 
termed MprF and has been reported to be a virulence factor (Peschel et al., 2001). 
 
Receptins 
Receptin denotes any microbial protein with affinity for a mammalian protein 
(Kronvall & Jönsson, 1999). The term receptin, parallels the term lectin, which is  
defined as a microbial protein with affinity for carbohydrates, a topic of great 
importance when studying adhesion of Gram-negative bacteria. Another term 
often used is adhesin, describing the determinant that provides adhesion, or 
attachment of cells, both prokaryotic and eukaryotic, to various structures and 
surfaces. An additional quite broad term is extracellular matrix-binding proteins, 
or ECMBPs, denoting soluble and surface-associated bacterial proteins binding to 
some component of the extracellular matrix (ECM) of the host (Flock, 1999). A 
related, but more narrow term is microbial surface components recognizing 
adhesive matrix molecules, or MSCRAMMs for short (Patti et al., 1994). 
 
Since this thesis deals both with secreted and cell wall-anchored staphylococcal 
proteins that bind to host proteins found in the blood, or associated with the 
extracellular matrix, the term receptins will be used throughout this thesis. 
S. aureus encodes a large number of receptin, many of which are well-studied. 
Much less is known about this class of molecules in other staphylococci, but the 
general view is that there are fewer to be found in other staphylococcal species 
compared to S. aureus. However, most S. aureus virulence factors, or equivalents 
probably also exist among the CoNS, but scattered between the different species. 
This thesis describes a novel surface-associated receptin of S. lugdunensis, and a 
novel secreted receptin of S. aureus, with many interesting features. 
 
Secreted proteins 
The secretory pathway, trafficked by most secreted proteins, recognises functional 
secretory signal peptides with certain characteristics. These comprise a few 
positively charged residues in the N-terminal of the protein to be secreted, 
followed by a central hydrophobic region, and a more polar region, which also 
includes the signal peptidase cleavage sequence, often involving alanines at the 
-3 and -1 positions (von Heijne, 1986). S. aureus produces a multitude of secreted 
proteins that fit into at least one of the categories toxin, enzyme, or receptin. 
Staphylococcal toxins are obvious virulence factors and they occur in many forms. 
One of the most striking features revealed about S. aureus, when the genome of 
two strains were sequenced a few years ago, was the existence of a large number 
of toxin genes (Kuroda et al., 2001). About 20 toxin genes were known at that 
time, and another 21 putative toxin genes were found. A great diversity of 
superantigen (SAG) genes were noted, and it is assumed that gene duplication 
frequently occurs, resulting in a very large number of different SAGs at the global 
scale. By contrast, the only toxin genes found in the recently released genome of 
S. epidermidis, were those for β- and δ-hemolysin (Zhang et al., 2003). Most 
strains of S. aureus secrete the commonly known cytotoxins, or hemolysins, 
designated α, β, γ, and δ, causing destruction of blood and tissue cells of the host   16
(Dinges, Orwin & Schlievert, 2000). α-toxin is hemolytic, cytotoxic, 
dermonecrotic, and one of the most potent toxins known (1 µg is often lethal to a 
rabbit). Erythrocytes, mononuclear immune cells, epithelial and endothelial cells, 
as well as platelets can be punctured by α-toxin. Monomers of this toxin insert 
either directly or via a high-affinity ligand into the lipid bilayer of a host cell, and 
polymerise to form cylindrical pores, usually with seven monomers each. The role 
of  β-toxin is not clearly understood, but it acts as a type C phosphatase, 
hydrolysing sphingomyelin in the host cell membranes. It is often the most 
abundant protein in S. aureus culture supernatants, particularly of animal isolates, 
sometimes yielding 20 mg per litre. Leukocidin, or Panton-Valentine leukocidin, 
and γ-toxin belong to the family of two-component toxins. They are so closely 
related that the different γ-toxin and leukocidin units can be combined, thus 
forming different mixed bicomponent toxins, all capable of efficient lysis of 
leukocytes. Their role in staphylococcal disease remains unclear. This is also the 
case for δ-toxin, a small 26 amino acid peptide encoded by a part of the regulatory 
RNAIII of the accessory gene regulator (agr) system, which will be discussed 
briefly later in this thesis. Most staphylococci produce δ-hemolysin. It resembles 
the bee venom mellitin, and the mode of action of δ-toxin has been compared to 
the disruptive effect of detergents on cell membranes. 
 
Common food poisoning occurs when staphylococcal enterotoxins (SEs), 
preformed in food contaminated with S. aureus, are ingested. If a localised 
S. aureus infection instead distributes the SEs systemically, they will act as SAGs, 
a group of powerful, pyrogenic and immunostimulatory exotoxins. Staphylococcal 
SAGs also include toxic shock syndrome toxin-1 (TSST-1), and they all induce a 
massive T-cell proliferation. SAGs may stimulate 5-30% of all T-cells, when 
present in concentrations measured in picogram ml
-1, while a normal antigen 
activates less than 0,01% of the T-cells under the same conditions. This highly 
unspecific T-cell stimulation is achieved by the simultaneous binding of a SAG to 
the T-cell antigen receptor and to the constant domains of a major 
histocompability complex (MHC) class II molecule of an antigen-presenting cell 
(APC), bypassing the need for any antigen to be processed and presented. This 
will lead to TSS manifested through an overwhelming release of host cytokines 
and inflammatory mediators, resulting in capillary leakage, hypotension, shock, 
multi-organ failure, and eventually death in approximately 5% of the cases. After 
the initial activation of the T-cells, most are eliminated through apoptosis and 
others become anergic, unable to respond to stimuli for a prolonged period of 
time. It is easy to envision that the role in vivo of the SAGs, must be to inhibit host 
immune responses to S. aureus. The main SAGs of staphylococci are TSST-1, 
responsible for menstrual TSS, and SE serotypes B and C, which together with 
TSST-1 are responsible for most nonmenstrual TSS (McCormick, Yarwood & 
Schlievert, 2001).  
 
Both in bullous impetigo and SSSS the typical flaking blisters of the superficial 
epidermis are caused by the action of staphylococcal exfoliative toxin (ET) 
(Farrell, 1999; Melish, Glasgow & Turner, 1972). The occurrence of similar 
symptoms, in an autoimmune disorder called pemphigus foliaceus, was explained 
some years ago (Mahoney et al., 1999). This work, in conjunction with an 
observed similarity between ETs and the serine protease superfamily, solved the   17
enigma of skin peeling in SSSS, and led to the identification of desmoglein 1 as 
the target of ET (Amagai et al., 2000; Rago et al., 2000). Desmosomes are the 
major type of intercellular adhesive junctions, and desmoglein 1 is a member of 
the cadherin family of calcium dependent cell-to-cell adhesion molecules, and the 
only desmosomal glycoprotein expressed in the upper epidermis. Consequently, 
when desmoglein 1 is specifically cleaved by the protease activity of ETs (either 
A, B, or D), the superficial layer of the skin detaches, leaving deeper granular 
layers exposed and highly susceptible to secondary infections (Amagai, 2003).  
 
Even though some toxins obviously are enzymes, these are generally not 
grouped with the staphylococcal exoenzymes, e.g. lipases, proteases, and 
nucleases. Exoenzymes are considered to be secondary virulence factors, whose 
main function is to convert local host tissues into nutrients required for 
staphylococcal growth. These proteins are found both in S. aureus and CoNS, e.g. 
S. epidermidis and S. lugdunensis. Certain lipases, fatty acid-modifying enzymes 
(FAME), from different staphylococcal species, have the potential to inactivate the 
bacteriocidal lipids found in staphylococcal abscesses (Arvidson, 2000). Various 
proteases can, besides provide nutrients, inactivate important host proteins, as 
exemplified by the V8 serine protease that can cleave all human immunoglobulin 
classes, thus putatively impairing the humoral host defence against the bacteria. 
Hyaluronidase, or more specifically hyaluronate lyase, is produced by S. aureus, 
but not by S. epidermidis. This exoenzyme is considered to contribute more to 
virulence than other, as it disrupts hyaluronic acid, one of the central components 
of the extracellular matrix, thus facilitating for S. aureus to penetrate into tissues. 
 
Secreted receptins are generally regarded as virulence factors. One important 
example is the extracellular fibrinogen-binding protein (Efb), which has been 
shown to be a virulence factor that delays wound healing in a rat model of 
S. aureus infection (Palma et al., 1996). Other important secreted receptins are 
coagulase and staphylokinase (SAK), which are sometimes considered as 
exoenzymes. However, since they are not true enzymes, but instead receptins, that 
bind and activate host enzymes through complex-formation with these, they will 
be discussed in the following paragraphs. 
 
Coagulase is a bifunctional receptin, with the capacity to bind fibrinogen via 
several C-terminal repeats, besides its well-documented ability to cause blood and 
plasma from several mammals to clot (Bodén & Flock, 1989). Coagulase is 
secreted by most strains of S. aureus, and is known to form an equimolar reactive 
complex with prothrombin (Hemker, Bas & Muller, 1975; Kawabata et al., 1985). 
The normal physiological activation mechanism of the zymogen prothrombin is by 
enzymatic cleavage into thrombin, the key effector enzyme in the blood 
coagulation cascade, which is described in more detail later in this thesis. 
Thrombin subsequently cleaves fibrinogen into fibrinopeptides and fibrin, which 
results in fibrin clotting, the ultimate product of coagulation. However, coagulase 
does not cleave prothrombin into thrombin, instead it acts as a cofactor, which 
induces a conformational change in prothrombin, resulting in an active complex, 
which also converts fibrinogen into fibrin. Virulence studies have been performed 
in different animal models with an isogenic S. aureus mutant, in which the gene 
encoding coagulase has been deleted. In two murine models of subcutaneous and   18
intramammary infection, no diminished virulence was noticed (Phonimdaeng et 
al., 1990). When the same mutant was used in a different mouse model of blood-
borne staphylococcal pneumonia, a possible role for coagulase was suggested in 
the later stages of infection (Sawai et al., 1997). Although the role of coagulase in 
pathogenesis is not resolved, the mechanism of prothrombin activation was 
recently explained in detail, when the crystal structure of coagulase in complex 
with thrombin was determined (Friedrich et al., 2003). This is discussed in more 
detail later on, as the novel secreted von Willebrand factor binding-protein 
(vWbp) of S. aureus, described in this thesis, also is a coagulase.  
 
As with coagulase and prothrombin, a reactive equimolar complex is also 
formed between SAK and plasmin(ogen), the host target of SAK (Collen, 1998). 
Plasminogen, the precursor form of plasmin, is very effectively activated by the 
SAK-plasmin complex. Activated plasmin is a broad spectrum serine protease that 
degrades fibrin clots and ECM proteins, except collagens. Instead, plasmin can 
activate latent procollagenases and other proteolytic enzymes, which in turn cause 
the degradation of collagens and ECM proteins in concert with plasmin. An 
assumed role for SAK during an infection is to release staphylococci trapped in 
fibrin clots, and to support bacterial metastasis, thereby promoting virulence and 
spread of bacteria to new sites in the host (Lähteenmäki, Kuusela & Korhonen, 
2000). Apart from S. aureus, some CoNS, e.g. S. lugdunensis, are reported to 
produce SAK (Sawicka-Grzelak et al., 1993). Evidence of SAK as a virulence 
factor of staphylococci is still lacking, but a large number of invasive bacterial 
pathogens express different receptins that use the host plasmin(ogen) system, thus 
enabling them to degrade host tissues, a feature assumed to contribute 
substantially to bacterial virulence (Lähteenmäki, Kuusela & Korhonen, 2001). 
 
Recently, a secreted chemotaxis inhibitory protein of S. aureus (CHIPS) was 
reported (De Haas et al., 2004). This putative receptin specifically impairs 
neutrophil chemotaxis towards excreted bacterial formylated peptides (FP), and 
C5a derived from the host complement system, both potent chemoattractants 
present during staphylococcal infections. The ligands of CHIPS are not yet 
identified, but possible candidates are the receptors for the above mentioned 
chemoattractants, FPR and C5aR. This suggestion was made since CHIPS was 
observed to bind specifically to neutrophils and monocytes expressing these 
receptors, and in amounts corresponding to the known levels of receptor-
expression by these cell types. The gene coding for CHIPS was isolated from 
S. aureus strain Newman, and was found to be located on the same bacteriophage 
as the genes encoding SAK, and also SEA, inserted into the chromosomal gene for 
β-toxin. As both SAK and SEA, which show pronounced human-specific action, 
CHIPS inhibits chemotaxis of human cells 30-fold more efficiently, compared to 
mouse cells (Dohlsten et al., 1993; Gladysheva et al., 2003; De Haas et al., 2004). 
 
Another very interesting secreted receptin, almost exclusively built up of 
repeated 110 amino acids domains, has been independently isolated and studied by 
different groups. Therefore the same protein is known as p70, and as the MHC 
class II analogous protein (Map), as well as the extracellular adhesion protein 
(Eap) (Jönsson et al., 1995; Palma, Haggar & Flock, 1999; Yousif et al., 1994). In 
a recent review, the numerous possible functions of this multifunctional protein   19
were outlined (Harraghy et al., 2003). Most of the produced Eap is secreted from 
the bacteria, and has been reported to bind several different host plasma proteins, 
e.g. fibrinogen, fibronectin, and prothrombin. Eap can also form oligomers and 
bind back to several structures on the surface of S. aureus. Thus, Eap could aid 
S. aureus adhesion to i.e. an indwelling medical device coated with host proteins, 
as well as promote intercellular aggregation of S. aureus. Further, Eap can 
facilitate both adherence and internalisation of S. aureus to, and into, epithelial 
cells and fibroblasts. Another target for Eap is ECM proteins and Eap also binds 
and blocks an endothelial cell receptor, intercellular adhesion molecule-1 
(ICAM-1), which thus prevents the extravasation of leukocytes, making Eap like 
CHIPS, an anti-inflammatory agent (Chavakis et al., 2002). The affinity of Eap for 
ICAM-1 might also disturb APCs in their interaction with T-cells, and moreover, 
Eap induces apoptosis, when interacting with T-cells (Lee et al., 2002). Especially 
the immuno-suppressing properties may be of significance for the outcome of an 
S. aureus infection. In one study, none of the mice infected with an S. aureus 
strain lacking Eap developed heart abscesses eight weeks post-infection, whereas 
almost 60% of the mice that received wild-type bacteria did (Lee et al., 2002). 
Taken together, this implies that Eap is an important virulence factor of S. aureus, 
at least in chronic infections. Eap exemplifies very well the inherent complexity 
and biological importance of this heterogeneous family of secreted receptins, that 
appears to have several independent, but to some extent overlapping, or even 
opposed functions, which in the end are elaborately interwoven.  
 
Cell surface associated proteins 
The partial redundancy and complexity described above is definitely also found 
among the rich repertoire of receptins, which are secreted and subsequently seized 
at the staphylococcal cell surface. Many surface proteins are anchored to the cell 
wall by a mechanism, that requires a C-terminal cell wall sorting signal, usually 
consisting of a conserved LPXTG-motif, followed by a hydrophobic domain and a 
tail of mostly positively charged residues (Mazmanian, Ton-That & Schneewind, 
2001). The LPXTG-residues of an exported protein are recognised by sortase, an 
enzyme on the outside of the bacterial membrane, which cleaves the protein 
between the T- and G-residues, and subsequently anchors the protein covalently to 
the pentapeptide cross-bridge of the cell wall peptidoglycan (Mazmanian et al., 
1999). From analysis of staphylococcal genomes sequenced so far, at least 22 
S. aureus , and 11 S. epidermidis surface proteins, have this motif (Mazmanian, 
Ton-That & Schneewind, 2001; Ponnuraj et al., 2003; Roche et al., 2003). The 
method of anchoring surface proteins via LPXTG, or an equivalent motif, is found 
to be very wide-spread among Gram-positive bacteria, and more than one sortase 
gene is usually found within each bacterial species (Pallen et al., 2001). For 
example,  S. aureus has a second sortase, that recognises a different and to 
S. aureus unique NPQTN-motif situated on a protein of so far unknown function 
but of importance for staphylococcal persistence in infected tissue (Mazmanian 
et al., 2002). S. aureus sortase-deletion mutants failed to process and display this 
type of surface proteins, and in mouse models, the virulence of the mutants was 
found to be attenuated (Jonsson et al., 2002, 2003; Mazmanian et al., 2000). In 
staphylococci, many of these surface proteins anchored by sortase have been   20
studied, and much is known with regard to their binding capacities, while others of 
still unknown function are regarded as putative receptins. 
 
Protein A, the now classical prototype of a cell wall-associated receptin, was 
studied when the sorting mechanism to the cell wall was elucidated in S. aureus 
(Schneewind, Model & Fischetti, 1992). Protein A is primarily recognised because 
of its specific binding of the Fc-domain of IgG via five homologous domains, 
named E, D, A, B, and C, which are composed of ~60 amino acids each (Sjödahl, 
1977; Uhlén et al., 1984). The binding of IgG in a non-immunogenic manner, 
appears to disguise the bacteria, and thereby protect them from phagocytosis by 
host immune cells. Further, protein A was recently demonstrated to bind von 
Willebrand factor (vWf), and also the protein gC1qR, e.g. found on the surface of 
adhered platelets (Hartleib et al., 2000; Nguyen, Ghebrehiwet & Peerschke, 2000). 
Consequently protein A may also serve as an adhesin. Animal model experiments 
with isogenic S. aureus mutants, without the gene encoding protein A, have 
confirmed this receptin to be a virulence factor (Gemmell et al., 1997; Patel et al., 
1987). Since this thesis describes two novel staphylococcal receptins with affinity 
for vWf, this will be discussed in more detail later on. 
 
Recent data, derived from crystal structure determinations, implicate that the 
structural organisation of staphylococcal cell wall-associated receptins, may be 
better represented by the fibrinogen-binding “clumping factors” (ClfA and B), 
from S. aureus, and by the fibrinogen-binding protein Fbe, also known as SdrG, 
from S. epidermidis (Hartford et al., 2001; McDevitt et al., 1994; Ni Eidhin et al., 
1998; Nilsson et al., 1998; Ponnuraj et al., 2003). The N-terminal surface-
directing signal peptide is followed by a fairly large and non-repetitive A-domain, 
where the fibrinogen-binding is located. After the A-domain follow the 
characteristic SD-dipeptide-repeats (SDR), which force the receptin to stretch 
away from the surface of the bacteria, due to the alternating hydrophilic and 
negatively charged amino acids. Finally, next to the SDR, the C-terminal cell wall 
sorting signal is found. In the SdrG/Fbe protein, two B-repeats of so far unknown 
function are located between the A-domain and the SDR. Another four surface-
associated proteins from S. aureus are also included in the SDR-family of putative 
receptins. These are SdrC, SdrD, SdrE, and the plasmin-sensitive protein (Pls) 
(Josefsson et al., 1998; Savolainen et al., 2001). In S. epidermidis, SdrF, and the 
untypical and LPXTG-less SdrH have been recognised (McCrea et al., 2000; 
Mazmanian, Ton-That & Schneewind, 2001). For all these, perhaps excepting 
SdrE, which is ~85% identical to the bone sialoprotein-binding protein (Bbp), the 
function is unknown (Tung et al., 2000). Recent work on the mechanism of 
ligand-binding by SdrG/Fbe has revealed a structural model that is applicable on 
many surface-associated receptins of  staphylococci and other Gram-positive 
bacterial species (Ponnuraj et al., 2003). The crystal structure of the binding 
region of SdrG/Fbe, with and without ligand has been solved, and a dynamic 
“dock, lock, and latch” mechanism was suggested. The A-domains of many 
surface-anchored receptins are composed of two or three IgG-like folds, and in a 
cleft between two of the domains, short linear sequences of their respective 
ligands are recognised, and bound. Following this docking of the ligand, a β-
strand of one of the IgG-like domains passes over the bound polypeptide, thereby 
locking it in place. Finally, the β-strand inserts itself as a latch into a gap between   21
two of the β-strands of the other domain, thus stabilising the overall structure. The 
previously observed conserved sequence motif, TYTFTDYVD, constitutes the 
back of the gap where the latching strand inserts itself (Josefsson et al., 1998; 
McCrea et al., 2000; Ponnuraj et al., 2003). Also, a conserved structural feature, 
with alternating small residues, which face the larger side chains of the 
TYTFDYVD-motif, is observed in the latching β-strand. Preliminary crystal 
structures and computer modelling place nine S. aureus, and five S. epidermidis 
surface receptins in this novel family, sharing the dock, lock, and latch mechanism 
of ligand binding. In S. aureus the members of this group of receptins are ClfA 
and B, the fibronectin- and fibrinogen-binding proteins (FnbpA and B), SdrC, 
SdrD, SdrE, and Bbp, and the collagen-binding protein, Cna (Jönsson et al., 1991; 
Patti, Boles & Höök, 1993; Signäs et al., 1989). Like SdrG/Fbe, with the 
exception of ClfA and B, these receptins have a few repeated B-domains after the 
A-domain, where additional ligand binding might occur. A major feature of   
FnbpA and B is their fibronectin-binding D-repeats, next to the cell wall sorting 
signal. However, based on data from NMR spectroscopy an extended tandem 
β-zipper model was recently proposed for the binding between several sequential 
domains of fibronectin, and β-sheets of FnbpA, both from within and outside the 
D-repeats (Schwarz-Linek et al., 2003).  
 
Despite their proposed shared dock, lock, and latch mechanism of ligand-
binding, these receptins obviously have distinct properties, e.g. with regard to their 
preferred ligands and different effects exerted upon the host. For example, ClfA 
binds the γ-chain of fibrinogen in a manner that inhibits adhesion of platelets to 
immobilised fibrinogen, indicating that the binding sites for an important platelet 
integrin and this staphylococcal receptin overlap (McDevitt et al., 1997). 
SdrG/Fbe binds and blocks the β-chain of fibrinogen (Davis et al., 2001). This 
interferes with fibrin clot formation and release of fibrinopeptide B, which 
otherwise act as chemoattractants on leukocytes. ClfB binds both the α- and β-
chain of fibrinogen (O'Brien et al., 2002b). In addition, ClfB binds to cytokeratin 
10, which is found in the exposed nasal epithelium, and thus ClfB is believed to be 
a major determinant in nasal colonisation and carriage of S. aureus. Animal model 
studies on some types of S. aureus infections have established ClfA and Cna as 
virulence factors (Patti et al., 1994; Hienz et al., 1996; Moreillon et al., 1995; 
Rhem et al., 2000). FnbpA and B may play an important role in the fibronectin-
dependent internalisation of S. aureus, even though S. aureus is mainly regarded 
as an extracellular parasite (Fowler et al., 2000; Joh et al., 1999). The 
internalisation is probably achieved by the formation of a fibronectin bridge 
between Fnbps and integrins on non-phagocytic host cells, in which the 
staphylococci may find a protected niche. Further, FnbpA was recently 
demonstrated to inhibit fibrin assembly during thrombin-induced clot formation 
(Matsuka et al., 2003). Also, FnbpA was shown to be a functional substrate for 
coagulation factor XIII, which stabilise fibrin clots by introducing covalent bonds 
between fibrin molecules. This finding indicates that S. aureus might be able to 
attach covalently to fibrinogen and fibronectin under certain conditions. 
 
The above described surface proteins are known to mediate adhesion of 
S. aureus to various host structures. The picture is a little more complex for the 
intriguing protein Pls, which instead prevents adhesion of intact S. aureus to   22
ligands like fibronectin, even when the fibronectin-binding adhesins are present 
(Hildén et al., 1996; Savolinen et al., 2001). The gene coding for Pls is not found 
in all S. aureus isolates, but is closely associated with the mecA gene coding for a 
penicillin-binding protein in MRSA (Ito et al., 2001). The expression of Pls thus 
explains the puzzling report on S. aureus strains defective in the adhesion to 
fibronectin and fibrinogen when a mecA element was present, even though the cell 
wall-associated receptins that bind these ligands were found in normal amounts 
(Vaudaux et al., 1998). Structurally, Pls does not have the TYTFDYVD-motif 
discussed above, but has a few repeated B-domains between the A-domain and 
SDR, and also several short repeats between the signal peptide and the A-domain. 
Pls is homologous to S. aureus surface protein G (SasG), and the accumulation-
associated protein (Aap) from S. epidermidis, which is of importance for the 
biofilm formation following the initial adhesion event (Hussain et al., 1997; 
Roche, Meehan & Foster, 2003). Pls has also been reported to promote bacterial 
aggregation and moreover, to bind lipids (Huesca et al., 2002). The SasG gene 
was found to positively correlate with isolates of S. aureus causing disease. 
However, no protein ligand has yet been found, neither for Pls, nor for Aap, but 
both Pls and SasG were found to promote bacterial adherence to nasal epithelial 
cells (Roche, Meehan & Foster, 2003). Preincubation with Pls, SasG or Aap 
inhibited this binding, indicating a common ligand for these adhesins, found to 
share a conserved domain in the A-domain. This conserved domain was also 
found in yet another LPXTG protein, SasA, exhibiting an untypical SX dipeptide 
repeat region. As mentioned earlier, Pls is sensitive to the proteolytic action of 
plasmin, and the cleavage site is immediately N-terminal of the conserved domain 
reported to bind nasal epithelium. It appears that bacteria expressing Pls can under 
certain conditions prevent adhesion and under other conditions promote adhesion. 
Possibly cleavage of Pls are involved in the regulation of these different qualities. 
Another surface anchored protein, the biofilm-associated protein (Bap), is 
composed of a relatively short non-repeated A-domain, which is preceded by a 
couple of short repeats, and followed by numerous longer repeats (Cucarella et al., 
2001). Bap is found in some strong biofilm producing bovine isolates of S. aureus, 
and is involved in adherence to inert surfaces, and intercellular adhesion of 
staphylococci. In an foreign body mouse infection model, Bap was found to be 
involved in the pathogenesis of persistent infections. Further, expression of Bap 
prevented initial attachment of S. aureus (Cucarella et al., 2001, 2002).  
 
Iron is an essential component for bacterial growth, and some genes are 
expressed when free iron is limited. This occurs during infection, since the iron 
inside the host is bound to different host proteins, like transferrin, haptoglobin, or 
hemoglobin. In this context four genes encoding additional putative receptins of 
S. aureus have recently been described, three thereof in close proximity to each 
other. These are the iron-responsive surface determinants, IsdA and IsdB, both 
containing the LPXTG motif, and IsdC, which contains the alternative sorting 
motif NPQTN mentioned previously (Mazmanian et al., 2002). In the same operon 
as the gene encoding IsdC are the gene for the second sortase and genes encoding 
a ferrichrome transporter. An alternative name for IsdA is StbA, staphylococcal 
transferrin-binding protein, which more clearly describes the function of this 
receptin, and yet another name is FrpA, for fur-regulated protein A (Morrissey   23
et al., 2002; Taylor & Heinrichs, 2002). Recently, IsdA was reported to possess a 
distinct domain with broad-spectrum ligand-binding activity recognising 
fibrinogen and fibronectin (Clarke, Wiltshire & Foster, 2004). IsdB is reported to 
bind hemoglobin, and even though IsdC binds heme-iron, the function of IsdC is 
not yet clear (Mazmanian et al., 2003). Separated from this gene cluster, is the 
fourth iron-regulated gene encoding a LPXTG-receptin, IsdH or HarA, which 
recently was demonstrated to bind haptoglobin (Dryla et al., 2003). 
 
Several receptins present on the surface of S. aureus lack the LPXTG motif but 
may still serve as adhesins. Among these is the second IgG-binding protein in 
S. aureus (Sbi), which also binds to β2-glycoprotein I (β2-GPI) (Zhang et al., 1998, 
1999). Sbi does not have the typical cell wall sorting signal and membrane 
spanning domain, but in the C-terminal end Sbi has a region with proline residues 
repeated every fifth amino acid, which is similar to other cell wall spanning 
domains (Uhlén et al., 1984; Guss et al., 1986). Further, an S. aureus receptin 
binding elastin, EbpS, has been reported, which does not even possess an N-
terminal signal peptide, but is instead an integral membrane protein (Downer 
et al., 2002; Park et al., 1996). Yet another class of staphylococcal surface 
receptins has been proposed, the autolysins/adhesins,  which show both 
autobacteriolytic enzymatic activity and affinity for host ligands. The 
autolysins/adhesins from S. epidermidis are Aae, demonstrated to bind vitronectin, 
fibrinogen and fibronectin, and AtlE, which binds to polymers, and vitronectin 
(Heilmann et al., 1997, 2003). Proteins homologous to AtlE from other species of 
staphylococci are reported to bind fibronectin (Allignet et al., 1999; Hell, Meyer 
& Gatermann, 1998). Another receptin, closely associated with the cell surface, is 
a recently described protein with a broad affinity for fibrinogen, fibronectin, 
collagen and vitronectin, named ECM protein-binding protein (Emp) (Hussain et 
al., 2001). Also, a major portion of Eap, previously mentioned under secreted 
proteins, binds back to the surface of S. aureus, and the surface-located neutral 
phosphatase has been identified as one docking ligand for Eap (Yousif et al., 
1994; Flock & Flock, 2001). Surface located receptins are sometimes found to be 
otherwise well-known proteins, which do unknown things at a surprising location. 
Plasmin(ogen) binding receptins, in both streptococci and S. aureus, were recently 
revealed to be the α-enolase, known as an intracellular key enzyme in the 
glycolytic pathway (Mölkänen et al., 2002; Pancholi & Fischetti, 1998). This is at 
first perplexing, but since glycolytic enzymes developed very long ago, it is not 
that odd that some have evolved extra functions. In fact, an increasing number of 
these moonlighting proteins are found to perform more than one function (Jeffery, 
1999).  
 
The most remarkable proteins recently reported are the giant fibronectin-binding 
proteins of S. aureus, and S. epidermidis, encoded by ORFs ~31,5 and ~30,5 kb in 
size, respectively (Clarke et al., 2002; Williams et al., 2002). The one in S. aureus 
is called Ebh, for ECM-binding protein homologue, and the other in S. epidermidis 
is called Embp, for ECM-binding protein, and at least one part, corresponding to 
30% of both proteins predicted sequences, is identical (Zhang et al., 2003). Ebh is 
predicted to be a surface protein of ~1100 kDa, and has been extracted from the 
cell wall fraction of lysed S. aureus bacteria. However, no size marker is available 
to estimate the actual size of the mature protein. As possible means to attach to the   24
bacterial surface, Ebh has in its C-terminal part a putative membrane-spanning 
domain and a putative peptidoglycan-binding repeat region, similar to those found 
in other Gram-positive species (Foster, 1993). Ebh has three repeat regions 
following the signal peptide and the non-repeated A-domain. The first, and third 
region only have a couple of repeats each, while the second consists of over 40 
repeats, each 126 amino acids long, thus constituting the major part of this huge 
protein. These repeats confer the observed fibronectin-binding capacity, and show 
homology to a major adhesin, an ECM-binding protein of a Streptococcus species, 
hence the name Ebh (Manganelli & van de Rijn, 1999). The coding sequence is 
present in the reported complete genome sequences of S. aureus, but it appears 
that a frameshift mutation has separated the coding sequence into two ORFs in 
some  S. aureus strains (Kuroda et al., 2001). Analysis of mRNA from 
S. epidermidis also revealed that the gene coding for Embp was expressed 
(Williams et al., 2002). Binding studies on Embp indicated that the fibronectin-
binding is separated from the site in fibronectin where FnbpA and B of S. aureus 
bind. Why some staphylococci express such large surface-associated receptins is 
currently an open question, but since they exist, some advantage must be gained.  
 
Gene regulation  
Since staphylococci can exist as commensals, causing disease is merely one of 
several possible lifestyles of these facultative pathogens. Thus, the virulence genes 
and the factors they express simply represent an adaptation to one specific 
environment, the one inside the hostile host. Also the differentiation into a 
protected biofilm community and back to planktonic bacteria again whenever 
suitable, might be regarded as another state of existence, which promotes 
staphylococcal survival in the host. When affronted with the numerous aspects of 
staphylococcal virulence, where the many potentiating factors comprise e.g. 
toxins, exoenzymes, both secreted and surface-associated receptins, it is obvious 
that the precise regulation of the genes encoding the virulence determinants is 
crucial. The accessory genes involved in pathogenesis are collectively known as 
the virulon. The correct sub-set of the virulon is expressed due to the action of an 
extensive regulatory network, which orchestrates the amount of expression of any 
given gene, at the appropriate time, location and nutritional status of the bacteria. 
Most of the work on virulence gene regulation in staphylococci has been done on 
S. aureus. Some important players identified include four two-component systems, 
agr,  Sae,  arlRS and SrrAB, an alternative stress-induced sigma factor, σ
B and 
numerous transcription factors, e.g. SarA and its homologues (Novick, 2003).  
 
As an example of an important virulence gene regulation mechanism the agr 
system will be discussed to some extent. The identification of a global regulator, 
agr, which affects the expression of most of the accessory genes, was a central 
advance in the field of staphylococcal virulence gene regulation research 
(Morfeldt et al., 1988; Peng et al., 1988; Recsei et al., 1986). The agr locus 
contains two divergent transcription units, RNAII and RNAIII. Under laboratory 
conditions, these are expressed during exponential phase in a manner dependent 
on bacterial density through quorum sensing, i.e. when the extracellular 
concentration of an autocrine octapeptide has accumulated to a certain level. The   25
RNAII transcript contains agrB, D, C, and A genes, in that order. The agrD gene 
encodes the propeptide AgrD, which is converted into the octapeptide, and 
subsequently secreted. In this process, the membrane protein AgrB, encoded by 
agrB, is likely to participate. The agrC and agrA genes encode a classical two-
component signal transduction system, where AgrC is the membrane-bound 
receptor for the autoinducing octapeptide, and AgrA is the cytoplasmic response 
regulator, which is required for the induced expression of both transcripts in the 
agr operon. The RNAIII transcript encodes the δ-hemolysin, but it is the RNAIII 
molecule, which is the effector of agr regulation. The RNAIII has a complex 
secondary structure with 14 hairpin loops, but the mechanism by which RNAIII 
regulates transcription is unknown. The net effect of RNAIII expression is that the 
genes encoding cell surface receptins, e.g. protein A, which are produced during 
early exponential phase, are down-regulated. Instead, genes encoding secreted 
toxins,  e.g.  α-toxin, and exoenzymes are switched on, and consequently these 
proteins are mainly produced during post-exponential growth. In the light of agr 
regulation, a model situation of a localised infection can be envisioned where 
newly adhered staphylococci, thus present at a low density, need their surface 
adhesins to hold on to the tissue. As the bacterial density and the octapeptide 
concentration increase extracellularly, the available nutrients are likely to 
decrease. At some point, the autoinducing octapeptide initiates the switch, 
resulting in a staphylococcal phenotype expressing, among other things, proteases 
capable of degrading both the surrounding tissues to release nutrients, and the 
anchoring adhesins of the staphylococci. This makes it possible for staphylococci 
to escape from the present location, to again up-regulate the expression of 
adhesins, and to seed into new sites. As indicated earlier, this and other effects are 
not by any means achieved solely by the regulatory action of the agr locus, but by 
the combined inputs from the extensive regulatory network as a whole. 
 
The  agr locus is widely distributed among the staphylococcal species, and 
several subtypes of the locus are even found within a species (Dufour et al., 2002). 
However, considerable sequence variation is found in the components AgrB, C 
and D from different species, subspecies, and subtypes. The consequence of this 
variety is that the octapeptide, which is autoinducing for one species or subtype, is 
instead inhibiting for other staphylococci (Ji, Beavis & Novick, 1997; Otto et al., 
2001). Competition and staphylococcal cross communication appear to occur on 
our skin between, e.g.  S. aureus and S. epidermidis, and this peptide 
argumentation seems to generally favour the existence of S. epidermidis. The 
importance of agr in staphylococcal virulence is confirmed in animal models, 
where agr mutants are less virulent (Abdelnour et al., 1993; Gillaspy et al., 1995). 
However, conflicting data are reported on the importance of agr expression during 
infections (Goerke et al., 2000, 2001). The in vivo expression of agr, and some 
genes known to be agr-regulated in vitro, were examined by reverse transcription-
PCR. From the observed expression patterns the agr activity appeared 
nonessential for the expression of α-toxin. Further, low levels of protein A 
expression was observed in spite of low levels of RNAIII. Instead, the mutation of 
sae resulted in severe downregulation of α-toxin expression, and thus, also other 
regulatory circuits than those characterised in vitro might be used by S. aureus 
during infections. Host factors 
Immune defence 
The host protection scheme against microbial infections includes an innate part, 
and an acquired, or adapted response (Figure 1). The innate part includes both the 
physical, chemical and microbiological barriers, and the innate branch of the 
immune system. The very first line of defence consists of the intact skin and 
mucous membranes, which generally are impermeable to infectious agents. A 
range of anti-microbial factors contributes to the barrier function, e.g. low pH 
secretions containing lactic acid and fatty acids. Also, several antimicrobial 
peptides are found in sweat, or on epithelial surfaces, like dermcidin, β-defensins 
and cathelicidin (Nizet et al., 2001; Schittek et al., 2001). Further, lysozyme is 
secreted into the tear fluids, and so is secretory IgA that is encountered very early 
in the defence of the mucous membranes, although IgA is a component of the 
acquired immune system, discussed in the next paragraph. In the lower respiratory 
tract, ciliated cells efficiently remove airborne bacteria entrapped in the mucus in a 
process called the mucocilliary escalator. Also the abundant resident microbial 
flora should be considered as part of the innate defence barrier against pathogens, 
both through competition for available nutrients, and by the production of 
antimicrobial compounds directed against other species. 
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Figure 1. The host protection scheme against bacterial infections includes both innate and 
adapted immunity for which S. aureus has several countermeasures (indicated in bold). 
When the skin barrier is breached, bacteria enter the wound. If the wound is shallow, 
staphylococci might not be able to penetrate further into the subcutaneous tissue, but local 
production of ET can cause skin blistering. If the wound extends deeper to also include 
blood vessels, this will initiate hemostasis and the innate immune system through thrombus 
formation. Via vWf, platelets adhere to the collagen in the basement membrane of the 
subendothelium, become activated and aggregate. The coagulation cascade is also 
activated, leading to fibrin clot formation. Activated platelets release chemokines, which 
attracts leukocytes, as well as antimicrobial peptides that kill bacteria (indicated by †). 
Bacteria can also be phagocytosed and killed by platelets. Thrombin, the key effector 
enzyme of the coagulation cascade, activates platelets efficiently and converts fibrinogen 
into fibrinopeptides and fibrin, which attract leukocytes and polymerise into a clot, 
respectively. S. aureus uses adhesins to attach to host molecules like vWf and fibrin(ogen). 
Other receptins like vWbp  and  coagulase, initiate coagulation without converting 
prothrombin into thrombin, thereby possibly avoiding release of platelet peptide. The 
expression of SAK, instead lead to the degradation of the fibrin clot and release of S. 
aureus.  Exoenzymes which degrade ECM can also be expressed by S. aureus, thus 
facilitating the spread through host tissue. Uptake of S. aureus by non-professional 
phagocytic host cells, like fibroblasts and endothelial cells, occurs through indirect 
interaction via a fibronectin bridge, formed between S. aureus adhesins and host cell 
integrins. The presence of S. aureus in blood activates circulating complement, which 
opsonises the bacteria and attracts leukocytes. Also antibodies in the blood can opsonise S. 
aureus, leading to ingestion of bacteria by professional phagocytes like monocytes, 
resulting in the release of different cytokines. This will cause upregulation of cell adhesion 
molecules (CAMs), both locally on endothelial cells and on recruited circulating leukocytes 
like polymorphonuclear neutrophils (PMNs). S. aureus can express proteins like CHIPS 
and Eap which inhibit the recruitment and extravasation of leukocytes, respectively. To 
avoid being opsonised and engulfed, S. aureus can bind different blood proteins e.g. 
antibodies, in a non-immune manner, thus masking themselves from phagocytes. S. aureus 
that have spread into the tissue often give rise to abscess formation in which the PMNs are 
less effective in killing staphylococci. The bacteria can produce FAME in order to protect 
themselves from bacteriocidal lipids. Bacteria that escaped from the abscess, can be 
ingested and killed by phagocytes like macrophages, which present bacterial antigens for 
Th-cells from the adaptive immune system. These will make macrophages more efficient in 
their killing, and cause them to release proinflammatory molecules. Th-cells also activate 
B-cells to produce specific antibodies. Even intracellular bacteria can be killed by Tc-cells. 
S. aureus sometimes produces SAGs, that stimulate T-cells in an unspecific manner, 
leading to massive cytokine release, severe inflammation, and possibly TSS. See text for 
further details and references. Adapted from Lowy (1998). 
 
The second line of defence is formed by the innate immune system, which 
comprises phagocytes, complement, cytokines and acute phase proteins (Parkin & 
Cohen, 2001). Two main types of phagocytes are encountered circulating in the 
blood, macrophages and polymorphonuclear neutrophils, which will act when 
physical barriers are breached. Neutrophils are the dominant type of white blood 
cells, although quite short-lived, while macrophages are more long-lived cells of 
monocyte lineage. During the very early stages of infection, activated 
macrophages release cytokines, which will stimulate division of precursor cells 
from the bone marrow, resulting in elevated levels of neutrophils. 
Chemoattractants and proinflammatory molecules cause neutrophils, and also 
other leukocytes, to home to the infected site, where they attach through 
upregulated adhesion molecules, present both on the leukocytes and on the cells of 
the infected tissue. Most of the tasks executed by the phagocytes, can also be 
performed by platelets. This is discussed later on in connection with the   28
coagulation process. Phagocytes have receptors recognising structures specific to 
microbes termed pathogen-associated molecular patterns, e.g. lipoteichoic acid. 
Phagocytes engulf microorganisms, forming intracellular vesicles that fuse with 
cytoplasmic granules with toxic content, which kills the microbes by a respiratory 
burst of oxygen radicals. This process is 100-fold more efficient if the microbe 
first is tagged, or opsonised, with specific antibodies or complement, for which the 
phagocytes have receptors. Some encapsulated organisms are protected from 
phagocytosis, unless opsonised. The complement system is activated in a cascade-
like manner and has multiple roles, e.g. acting as chemotactic and bacteriolytic 
compounds. Proinflammatory cytokines and bacterial products cause cells in 
general to produce particular cytokines, called inflammatory chemokines, which 
act as chemoattractants with longer duration than e.g. complement. Inflammation 
causes swelling of the affected tissue, allowing easier access for the recruited 
phagocytes. Collectively, these defence mechanisms are unspecific. 
 
  The third line of defence, the antigen-specific immunity needs some time, 
measured in days, or even weeks, in order to gain momentum, but in the later 
phases of infections it is of major importance as it is adapted to the present 
infectious agent. The adaptive part of the immune defence consists of a cell 
mediated immune response through T-lymphocytes divided into T-cytotoxic (Tc) 
and T-helper (Th) cells, and an antibody-mediated immune response through B-
lymphocytes (Parkin & Cohen, 2001). Those T- and B-cells that specifically 
recognise a foreign antigen are activated to undergo proliferation. T-cells destined 
to become Tc-cells must have an antigen presented bound to a MHC I molecule on 
a nucleated cell harbouring an intracellular infectious agent, and if the T-cell 
receptor recognises the antigen it may become a Tc-cell capable of killing infected 
cells, or intracellular pathogens (Kaufmann, 1999; Stenger et al., 1999). T-cells 
meant to be Th-cells must instead recognise an antigen presented bound to a 
MHC II molecule on an APC in order to become a Th-cell. A subpopulation of the 
Th-cells can activate macrophages, and in this way help killing the pathogens. 
Another subpopulation of the Th-cells supports the activation of B-cells, that 
recognise the antigen specifically. Activated B-cells are transformed into plasma 
cells, which secrete huge amounts of specific antibodies, that most often can 
neutralise their antigens and stimulate phagocytosis. Memory cells formed after an 
infection will cause a stronger and faster acquired immune response, if the 
infectious agent is encountered another time. 
 
However, sometimes a encountered pathogen is not so easily defeated. The 
hallmark of an S. aureus infection is abscess formation. An abscess can form e.g. 
when S. aureus enters into the host tissue, but without being able to penetrate into 
the circulation. This gives rise to a localised infection, screened off by the 
formation of a capsule of ECM components produced by the host in order to 
contain the infection, and thus prevent it from reaching the circulation. Immune 
cells, predominantly neutrophils, will be recruited to a localised infection through 
chemoattractants, and these cells can enter into the abscess and ingest the bacteria. 
However, once abscesses have formed, they tend to be chronic in nature, and 
neutrophil localisation and chemotaxis have been reported to be impaired at this 
stage (Bamberger, Bettin & Gerding, 1987; Bamberger et al., 1989). Moreover, 
neutrophils have a diminished capacity of neutralising staphylococci in the abscess   29
milieu, which probably contributes to the fact that the bacteria often persist inside 
an abscess until it is drained (Bamberger & Herndon, 1990).  
 
Extracellular matrix 
The ECM comprises any molecule secreted and immobilised outside cells. 
Accordingly, ECM is an extremely complex and varying mixture of proteins, 
glycoproteins, proteoglycans, and hyaluronic acid, which provides both structure 
and function. ECM contributes most significantly to the different and unique 
structure of each type of tissue in our body (Reichardt, 1999). The components in 
ECM can broadly be divided into fibrous elements, e.g. collagen and elastin, into 
link proteins, e.g. fibronectin and laminin, and into space filling molecules, like 
glycosaminoglycans. These molecules, in company with many other, provide 
tissues with three-dimensional structure, tensile strength, and attachment sites for 
cells. Further, ECM holds a reservoir of signalling factors, e.g. cytokines and 
growth factors, that modulate as diverse functions as inflammation, cell migration, 
orientation, differentiation, proliferation, angiogenesis, wound healing and 
immune responses. ECM is a dynamic scaffold for tissue morhpogenesis, 
maintenance, and reconstruction of tissue following an  injury (Badylak, 2002). 
The most abundant proteins in ECM are different types of collagens, which 
together constitute ~1/3 of the total protein content in mammals. In the ECM 
underneath the barriers posed by the skin and mucosal layers in the body, mainly 
type I collagen is found. The ECM forming the basement membrane, directly 
beneath the endothelial cells of blood vessels, is instead mainly composed of 
collagen type IV and laminin. As long as the tissues are intact, these are major 
obstacles that an invading pathogen has to penetrate to reach the blood circulation.  
 
Platelets and coagulation 
In order for the host to maintain the vital hemostasis and to defend itself against 
pathogens, a self-sealing defence mechanism has evolved that responds to any 
vascular damage, and also to bacteria entering the vasculature. This system of 
blood coagulation follows a complex scheme comprising an extensive interplay 
between vascular endothelium, platelets, plasma proteins promoting coagulation, 
other proteins inhibiting coagulation, and fibrinolytic proteins (Pasi, 1999). These 
components are ready to be rapidly activated, but normally the system is balanced 
in favour of anticoagulation to assure the free flow of blood in the vascular 
system. Following a blood vessel injury, the first response is an immediate 
vasoconstriction, both of the damaged vessel and of vessels in adjacent tissues, 
thus reducing the blood flow into the damaged area. At the point of damage, the 
endothelial cells no longer cover the subendothelial ECM, which instead is 
exposed to the components of the blood. A couple of crucial proteins in the blood 
will bind to the uncovered ECM, predominantly to collagen, and also to specific 
integrin receptors on the circulating platelets, thus serving as interconnecting 
adhesion molecules. The bridging proteins, i.e. vWf and fibrinogen, will in concert 
contribute to the initial adherence and the subsequent aggregation of platelets, but 
to a varying degree depending on the velocity of the blood within the damaged 
vessel (Ikeda et al., 1991; Savage, Saldivar & Ruggeri, 1996). Since these proteins are of central importance for this thesis, they will be discussed in some detail in 
the following paragraphs in the context of hemostasis.  
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Figure 2. Schematic representation of vWf with the different repeated domains indicated 
(A-D), and some of their binding capacities specified above: FVIII, factor VIII; GPIb, 
glycoprotein Ibα; Cn, collagen; Integrins, e.g.  αIIbβ3. Abbreviations: N, N-terminal; SP, 
signal peptide C, C-terminal; S-S, disulphide bridges responsible for multimerization and 
dimerization. Indicated below are clones representative for the four major groups of clones 
isolated when a vWf-cDNA phage display library was panned against polyclonal anti-vWf 
antibodies, as discussed later in this thesis. Adapted from Vischer & de Moerloose (1999).  
 
Endothelial cells produce vWf, which is stored in intracellular granules called 
Weibel-Palade bodies, and secreted both into the ECM, and into the blood, which 
holds a vWf-concentration of  ~10 µg ml
-1. Megakaryocytes, the cell type 
responsible for platelet production, synthesise the vWf stored within the α-
granules of platelets (Vischer & de Moerloose, 1999). The mature form of vWf is 
a large multifunctional glycoprotein, consisting of 2050 amino acids arranged in 
four different types of repeats, which are denoted A-D (Figure 2). Homodimers of 
vWf, ~540 kDa in size, are most often combined to multimers of different sizes, 
the largest up to several thousand kDa (Ruggeri, Dent & Saldivar, 1999). One 
important function of vWf is to bind and protect factor VIII of the blood 
coagulation cascade from degradation. Further, vWf is absolutely essential for the 
initial attachment of platelets during rapid arterial blood flow, even though 
fibrinogen also participates in the platelet aggregation that follows, which results 
in the formation of the primary hemostatic plug (Ruggeri, Dent & Saldivar, 1999; 
Matsui et al., 2002). vWf mediates platelet adhesion through two distinct platelet 
receptors, the glycoprotein Ibα in the glycoprotein Ib-V-IX complex and the 
glycoprotein IIb-IIIa, also called integrin αIIbβ3. The former interaction causes the 
platelets to slow down and roll across the subendothelial surface. This transient 
type of interaction activates the integrin αIIbβ3, causing platelets to bind 
irreversibly to the RGD-sequence of vWf. During the process, platelets become 
activated, which results in degranulation and a dramatic change in shape, features 
that promote further platelet aggregation and activation. 
 
  Parallel to the process of platelet plug formation, the circulating components of 
the blood coagulation cascade are activated from their resting pro-forms into 
activated serine proteases, assembled in complexes at the lipid surfaces derived 
from the inner leaflet of activated platelets (Lentz, 2003). This is mainly initiated 
through an integral transmembrane protein called tissue factor, found in 
abundance on the surface of vascular cells, but also to some extent on nonvascular 
cells. The tissue factor protein on damaged cells binds to the circulating factor VII, 
some of which already exists in an active form. This particular complex formation 
triggers coagulation by cleaving the factors IX and X into their active states, IXa 
  30and Xa (Butenas & Mann, 2002; Dahlbäck, 2000). The factors IXa and Xa bind 
the activated factors VIIIa and Va, respectively (see below), and thus form the 
complexes which activate factor X and prothrombin into Xa and thrombin, 
respectively. Thrombin is the principal effector enzyme of the coagulation cascade 
(Figure 3). Most importantly, thrombin causes the conversion of fibrinogen into 
fibrin by removal of the highly anionic fibrinopeptides A and B. This modification 
exposes otherwise hidden positively charged binding structures with affinity for 
negatively charged sites on neighbouring molecules (Doolittle, 2003). This causes 
fibrin monomers to rapidly polymerise into a fibrin clot, the gel-like network that 
reinforces the primary platelet plug and hopefully stops the bleeding. Other vital 
functions of thrombin concern activation of platelets, and the feedback 
amplification through activation of several factors involved in the coagulation 
cascade, e.g. factors V, VIII, and also XI that activate factor IX (Dahlbäck, 2000; 
Butenas & Mann, 2002). Further, thrombin activates factor XIII, which catalyses 
the reaction that covalently cross-links fibrin molecules, thus hardening the 
initially soft fibrin clot. The coagulation system is under tight regulatory control 
through the serine protease inhibitors termed tissue factor pathway inhibitor and 
antithrombin, as well as by the activation of protein C on intact endothelial cells. 
Activated protein C inactivates the active factors Va and VIIIa by proteolytic 
degradation. Recently β2-GPI, was demonstrated to inhibit the activation of factor 
XI (Shi et al., 2004). In order to ensure unimpeded blood flow, a fibrinolytic 
system exists, that will degrade and remove any surplus deposited fibrin (Collen & 
Lijnen, 1991). This system consists of inactive plasminogen, the plasminogen 
activators, e.g. tissue plasminogen activator, plasmin, the active fibrinolytic serine 
protease, and plasmin inhibitors. This system will ultimately act to remove the 
temporary repair patch, the fibrin clot, as the wound heals beneath it. 
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Figure 3. A simplified outline of the revised coagulation cascade. The most central 
components with regard to this thesis are underlined. Tissue factor and factors Va and VIIIa 
act as cofactors (shown in bold), which greatly enhance the enzymatic rate. The inhibitors 
indicated are: TFPI, tissue factor pathway inhibitor; β2-GPI,  β2-glycoprotein I; AT, 
antithrombin; PCa, activated protein C. See text for details. Adapted from Pasi (1999). 
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Platelets have multiple roles, one of which is to participate in the antimicrobial 
host defence. They circulate in abundance and respond to chemotactic stimuli. 
Consequently they are an important part of the innate immune defence at sites of 
microbial colonisation of vascular endothelium (Yeaman & Bayer, 1999). Platelets 
have receptors and granules comparable to leukocytes, and are capable of 
internalising microbial pathogens. Further, they generate antimicrobial oxygen 
metabolites, and upon activation by thrombin, they release various antimicrobial 
peptides (Tang, Yeaman & Selsted, 2002). Platelets aid the recruitment of 
leukocytes to a vascular injury, and in conjunction, they form a defence against 
pathogenic bacteria, e.g. staphylococci, that might enter the bloodstream through a 
wound. However, despite these host defence efforts, staphylococci are sometimes 
able to evade the immune system, colonise and cause septicemia.  
 
Other factors 
How an opportunistic pathogen like S. aureus is met by the host depends on many 
factors. The course and outcome of an infection will be affected by the general 
condition of the host, including factors as nutritional status, age, underlying 
disease, general immune status, and more specifically, if the host has been infected 
by this organism before, and if that infection gave rise to a protective acquired 
immunity. Generally, humans have antibodies directed against antigens from 
staphylococci as a result of colonisation. However, it is not certain that the 
immune response was of such quality that it is able to protect the host during a 
subsequent infection, since in spite of antibodies elicited in response to an 
invading pathogen can be of protective, non-protective, or even disease-enhancing 
character (Casadevall & Scharff, 1995). In the case of  S. aureus, antibodies raised 
often seem to be non-protective, since the presence of specific antibodies, people 
get reinfected. Further, S. aureus can affect immune cells of the host in several 
ways, some of which are discussed earlier in this thesis.  
 
One thing that seems to greatly influence the risk of acquiring an S. aureus 
infection, e.g. during surgery, is the nasal carrier state (Herwaldt, 2003). Some 
people are persistent carriers of S. aureus, some are intermittent carriers, whereas 
others appear to be permanent non-carriers (VandenBergh et al., 1999). One 
explanation to these differences might be variations in certain host factors, e.g. 
cytokeratin 10, supposed to be of importance for nasal adherence of S. aureus 
(O’Brien et al., 2002b). If host factors, important for S. aureus carriage or non-
carriage, could be established, new and exiting possibilities for anti-staphylococcal 
therapies would open. 
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Present investigation 
 
“If we knew what it was we were doing, it 
would not be called research, would it?” 
Albert Einstein 
 
Aims of the study 
The specific objectives of this thesis were to identify novel receptins from some 
important pathogenic staphylococci, and to study their interactions with host 
proteins. These goals were set up against the background of the increased 
antibiotic resistance observed among staphylococci at a global scale, which has 
prompted new efforts to elucidate the virulence mechanisms and to develop 
vaccines against these persistent opportunistic pathogens. In this regard, all 
receptins are of interest, since these are the contact points between bacteria and 
host. By targeting such key events, the infection process might be prevented, 
either by passive, or active immunisation. Although the genome of S. aureus now 
is sequenced, there is still a need to uncover the actual function of putative gene 
products. In our search for novel receptins, the powerful method of phage display 
was applied. Libraries derived from S. aureus and S. lugdunensis were constructed 
and affinity selected against ligands of interest with regard to severe infections, 
like catheter-related septicemia and endocarditis.  
 
Phage Display 
Basic phage display 
Phage display has evolved as a dynamic and resourceful technique for the 
identification and characterisation of interactions between proteins, since the proof 
of concept was first established (Smith, 1985). This was achieved by insertion of a 
foreign gene fragment in fusion with a gene encoding a coat protein of a 
filamentous phage, resulting in display of the corresponding fusion protein on the 
surface of the phage particles produced. By affinity selection, against an antibody 
specific for the foreign peptide, these phage particles could be isolated and 
enriched more than 1000-fold from a background of wildtype phage particles. One 
of the fundamental aspects of phage display is the direct physical link between 
displayed phenotype, and genotype of a phage particle.  
 
Filamentous phage of the Ff group infect Escherichia coli via the F pili. 
However, the infected cells are not killed, instead they continue to grow and 
divide, while secreting progeny phage particles (Russel, Linderoth & Sali, 1997). 
The phage genome encodes 11 proteins, five are coat proteins. Protein III (pIII) is 
a minor coat protein, important for infectivity, and located in a few copies at one 
end. A few thousands copies of the major coat protein, pVIII, cover the surface of 
the phage particle. In different phage display applications, these two coat proteins 
are generally employed (Azzazy & Highsmith, 2002; Smith & Petrenko, 1997).   34
Insertion of foreign DNA directly into one of the coat protein genes of the phage 
genome makes every copy of the corresponding coat protein a fusion protein. This 
practice has severe limitations concerning the range of tolerated foreign peptides. 
Instead, phagemid vectors with features from both phage and plasmid enables 
display of just one, or a few fusion proteins on the surface of phagemid particles, 
when the other wild type phage proteins are supplied in trans through a helper 
phage (Bass, Greene & Wells, 1990). Alternatively, a second copy of the gene 
encoding the coat protein can be inserted into the phage genome and used for the 
cloning of foreign DNA. The most common application of phage display is 
affinity selection, or panning of large libraries displaying short random peptides, 
or the variable domain of antibodies against some ligand of interest. The ligands 
employed range from defined ligands to exceedingly complex ligands, e.g. 
targeting organs in vivo (Pasqualini & Ruoslahti, 1996). 
 
Shotgun phage display 
A special variant of the general phage display method is shotgun phage display, 
which we have employed as a forceful instrument for studying interactions 
between bacterial and host proteins (Jacobsson & Frykberg, 2001; Jacobsson et 
al., 2003). Such libraries are constructed from bacterial chromosomal DNA, which 
is randomly fragmented and inserted into a phagemid vector. If large enough, the 
resulting library should theoretically consist of phagemid particles expressing 
polypeptides corresponding to all genes encoded by the organism of choice. By 
panning such a library against a ligand of interest, binding polypeptides can be 
isolated and putative receptins identified. Also panning against a complex mixture 
of ligands, e.g. serum, is feasible (Jacobsson & Frykberg, 1998). From an bacterial 
gene already cloned, or eukaryotic cDNA, it is possible to further map a binding 
domain by isolation of overlapping peptides.  
 
The phagemid vector pG8SAET, which gives rise to multivalent display of 
pVIII fusion proteins, has been used in this thesis. Libraries made with this vector 
often result in a high frequency of correct clones, when panned against an 
appropriate ligand. This vector also contains an expression screening tag (E-tag) 
useful for identification of correct clones. 
 
Results and discussion 
A novel vWf-binding protein and coagulase of S. aureus (I, II) 
Intravascular infection is a grave complication of invasive S. aureus disease, 
which requires bacterial attachment to thrombi, or subendothelium, for 
colonisation to occur. A few years ago, S. aureus was reported to bind to vWf-
coated surfaces, suggesting a role for vWf-binding in the pathogenesis of 
intravascular infections (Herrmann et al., 1997). Thus, we used shotgun phage 
display to identify vWf-binding receptins in S. aureus. Our work with the 
characterisation of a vWf-binding receptin was well underway, when an article 
appeared, describing protein A as the vWf-binding adhesin of S. aureus (Hartleib 
et al., 2000). However, we had instead found a secreted vWf-binding protein (I).  
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  The library derived from S. aureus strain Newman was panned against human 
recombinant vWf. This resulted in a specific enrichment of binding phagemid 
clones. Of 32 clones isolated and sequenced, 26 clones had overlapping inserts, 
suggesting that a gene encoding a hitherto unknown vWf-binding receptin had 
been identified. The gene was named vWb, and the corresponding protein vWbp, 
for von Willebrand factor-binding protein. With the aid of available genome 
sequence from S. aureus strain COL, the complete vWb gene was PCR-cloned 
from strain Newman. This gene is present in all S. aureus genome sequences 
publicly available today, as well as in the seven other strains we have examined. 
There seems to exist at least three different variants, with the deduced gene 
products being approximately 80% identical to each other. In the genome of S. 
aureus strain COL, and other strains, the vWb gene is located between the genes 
encoding ClfA and Emp, already discussed in the introduction of this thesis. The 
two genes that follow next encode a nuclease, and a small putative receptin of so 
far unknown function. This putative receptin is of special interest to this study 
since the sequence is homologous with the C-terminus of vWbp, as discussed later 
on. Virulence genes are quite often encountered in groups (Hacker et al., 1997), 
and since ClfA is a recognised virulence factor, the mentioned neighbouring genes 
can be considered to encode putative virulence factors, guilty by association.  
 
vWbp comprises 508 amino acids, with an N-terminal signal peptide of 26 
amino acids. From the panning experiment the vWf-binding region was mapped to 
26 amino acids, corresponding to amino acids 333 to 358 of the mature receptin. 
The lack of any apparent surface retaining features suggested that vWbp is a 
secreted protein, which was confirmed by purification and subsequent N-terminal 
sequencing of vWbp from the culture supernatant.  
 
Several independent lines of evidence imply that the interaction between vWbp 
and vWf is specific. Phagemid particles, displaying a major part of vWbp, were 
panned separately against different immobilised ligands, and generally, 1000 to 
10000-fold more phagemid particles bound to vWf than to the other tested ligands. 
This binding was inhibited by vWbp-specific antibodies in a dose-dependent 
manner. Also, a recombinant peptide, comprising the minimal binding domain of 
26 amino acids from vWbp, inhibited the interaction between vWbp and vWf in a 
dose-dependent manner (Bjerketorp, unpublished observation). Further, vWbp 
from an S. aureus supernatant also bound to vWf in a Western blot assay. 
Moreover, a part of vWbp, corresponding to amino acids 124-392 of the mature 
vWbp, could capture vWf from human serum when immobilised on a column. 
Accordingly, vWbp can bind both immobilised and soluble vWf.  
 
  As vWf is an essential component in blood clotting and interacts with many 
different molecules, we wanted to locate the domain in vWf to which vWbp binds, 
as this might help to elucidate the biological function of this interaction during 
infection. Three different strategies were used to identify the binding motifs in 
vWf. First, a random peptide library was panned against vWbp, to find binding 
peptides that perhaps resembled amino acid motifs in vWf. However, no vWbp-
binding peptides were obtained, instead some peptides with very good plastic-
binding ability were enriched. Secondly, cDNA encoding vWf was used to make a 
phage display library. Unfortunately, no enrichment was obtained when this   36
library was panned against vWbp. Thus, most likely, vWbp binds to a domain in 
vWf, which is not correctly folded at the phage surface, or that requires 
posttranslanational modifications for the interaction. Thirdly, we also had access 
to polyclonal antibodies against vWf, that efficiently inhibited the binding 
between vWbp and vWf. Thus, a significant fraction of the antibodies must be 
directed to the domain bound by vWbp. The cDNA library was panned against the 
antibodies, and a specific enrichment of binding phagemid particles was obtained. 
The insert of a large number of clones was determined, and almost all inserts were 
derived from four distinct regions in vWf (Figure 2). Two groups mapped in close 
proximity to crucial regions located in the domains A1 and C1 in vWf. These 
regions are e.g. involved in initial platelet adherence and aggregation, respectively. 
However, we have not yet been able to demonstrate that one of these important 
regions of vWf is the target for vWbp.  
 
If vWbp does bind to one of these key domains of vWf, this might hamper 
platelet plug formation, or platelet activation. As vWbp can initiate coagulation 
without converting prothrombin into thrombin (as discussed later), which is a 
powerful platelet activator, it might be possible for S. aureus to divert the release 
of bacteriocidal platelet peptides in a wound. It has been shown that the 
fibrinogen-binding receptins coagulase and Efb can bind platelets (Heilmann et 
al., 2002). Coagulase also avoids thrombin-formation when initiating coagulation, 
and Efb stimulates fibrinogen-binding to activated platelets, but simultaneously 
delays wound healing by inhibiting fibrinogen-dependent platelet aggregation 
(Palma et al., 2001). Acting together, these secreted receptins might make thrombi 
less bacteriocidal and more suitable for S. aureus colonisation. However, the 
scheme is very complex and far from understood, since several surface-anchored 
S. aureus adhesins can promote platelet aggregation by binding to platelets, which 
is reported to be important in the pathogenesis of endocarditis (Nguyen, 
Ghebrehiwet & Peerschke, 2000; O'Brien et al., 2002a; Sullam et al., 1996). 
 
  Interestingly, a moderate sequence similarity was observed between vWbp and 
coagulase. When vWbp was mixed with rabbit plasma from a commercially 
available coagulation test, it was found that the homology reflected a conserved 
function. Thus, like coagulase, vWbp is a bifunctional protein with ability to both 
bind a protein relevant for host hemostasis, and to induce coagulation (II).  
 
To further investigate the coagulating ability of vWbp, plasma from different 
animal species were mixed with vWbp. Plasma from several of the species tested 
were sensitive to the action of vWbp, but to a varying degree. Most strikingly, 
human plasma and also porcine plasma coagulated within one minute. Rabbit 
plasma was found to coagulate quite poorly and plasma from e.g. mouse not at all. 
In order to investigate this species variation, human plasma was added to plasma 
from e.g. mouse and rabbit, to a final concentration of 1%. The vWbp-induced 
coagulation time was now reduced to 10 minutes. Thus, a species-specific 
determinant was responsible for the observed differences in coagulation time. 
Since it is known that coagulase interacts with prothrombin (Hemker, Bas & 
Muller, 1975; Kawabata et al., 1985), we tested if prothrombin was the component 
with which vWbp interacted in a species-specific manner. Plasma from e.g. mouse 
and rabbit was mixed with vWbp and human prothrombin. Now coagulation   37
occurred within one minute, whereas the same experiment with bovine 
prothrombin did not reduce the time for coagulation. From these experiments it 
appears to be the effectiveness of prothrombin activation, that determines the 
species-specific coagulation by vWbp. Interactions between pathogens and their 
hosts eventually lead to evolutionary effects on both parties. Thus, the emergence 
of bacterial virulence factors, tuned to their hosts, is to be expected. 
 
The coagulation was easily monitored by mixing human plasma and vWbp in a 
spectrophotometer cell. Coagulation was inhibited in a dose-dependent manner by 
addition of antibodies against vWbp, but not by addition of antibodies against 
coagulase. When vWbp and coagulase were mixed in equine plasma, specific 
antibodies against both these proteins were needed in order to inhibit the reaction. 
Although vWbp and coagulase have similarities, antibodies against the respective 
protein show almost no cross-reactivity in a Western blot assay. As a 
consequence, antibodies against both vWbp and coagulase, might be required in 
order to fully inactivate the coagulating ability of S. aureus.  
 
When truncated variants of vWbp were expressed and examined, only the first 
250 amino acids were needed for coagulation, while an N-terminally truncated 
vWbp was inactive.  These findings are in accordance with the recent study 
published during the course of our work (Friedrich et al., 2003). This reported on 
the crystal structure of coagulase bound to human prothrombin and thrombin, the 
mechanism of prothrombin activation by coagulase, and also proposed a domain 
organisation of vWbp based on homology to coagulase (Figure 4). The first 150 
amino acids of coagulase, the D1 domain, activate prothrombin by inserting the 
N-terminal amino acids into an activation pocket of prothrombin. The following 
111 amino acids, the D2 domain, are required for the proper binding of 
prothrombin. The corresponding D1 and D2 domains in vWbp were proposed to 
comprise the first 131, and the following 130 amino acids, respectively. A novel 
fold with a three-helix bundle in each domain was described, and the fold was also 
observed in other putative receptins from Streptococcus  agalactiae  and 
Streptococcus pyogenes. Kinetic experiments stressed the importance of an intact 
N-terminal of coagulase, since addition or removal of one amino acid, 
significantly reduced the prothrombin activating ability. The N-terminal amino 
acids of the recombinant vWbp used in our study were determined, and found to 
be identical to the native vWbp. However, our recombinant coagulase 
unfortunately contained an additional alanines residue (A-coagulase), introduced 
due to cloning constraints in the expression system. Most likely, the coagulating 
activity of A-coagulase does not reflect the full activity of native coagulase. The 
A-coagulase variant with an extra alanine, a residue with a small side chain, could 
still be more active than the coagulase reported by Friedrich et al. (2003), which 
had an extra methionine, a residue with a larger side chain. Also, the known 
species-specificity of coagulase are retained, since A-coagulase coagulates rabbit 
plasma better than plasma derived from any other species. 
 
The similarities between vWbp and coagulase were found to extend even 
further. When mixing vWbp or coagulase with human prothrombin, the respective 
receptin is trimmed in the C-terminus, releasing 77 or 136 amino acids, 
respectively. The part released from vWbp corresponds to roughly half the putative receptin encoded by the last gene in the clfA-vWb gene cluster earlier 
mentioned (Figure 4). The similarities between the two proteins are high in their 
C-terminals (~70%), but drops to below 20%, immediately upstream of the 
cleavage site. Conceivably, this small homologous protein originated through gene 
duplication of vWbp, followed by deletion of the domains responsible for 
coagulation and vWf-binding. In coagulase, the C-terminal cleavage corresponds 
to the release of all fibrinogen-binding repeats. It remains to be elucidated whether 
these fragments are released also in vivo, and what functions they possibly serve. 
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Figure 4. Alignment of vWbp from S. aureus strain Newman and coagulase from S. aureus 
strain 8325-4. Abbreviations: SP, signal peptide; aa, amino acids; vW, von Willebrand 
factor-binding region; Fg, fibrinogen-binding repeats. The human prothrombin cleavage 
sites are indicated (arrows), as are the domains (D1 and D2), responsible for activation and 
binding of prothrombin, respectively. Adapted from Friedrich et al. (2003). vWbp is also 
aligned against the small putative receptin located in the same gene cluster as vWbp. The 
question mark indicates an unknown function.  
 
SAK-activation of human plasminogen dissolves fibrin clots, thus counteracting 
the clotting reaction induced by vWbp and coagulase. This is particularly 
interesting in view of a recent study, showing that the expression of SAK is 
inversely correlated to virulence of S. aureus in human infections (Jin et al., 
2003). Thus, isolates of S. aureus from nasal carriers, or non-lethal bacteraemia, 
had a higher SAK-expression than S. aureus isolated from patients with lethal 
bacteraemia. It is possible that the SAK-expression counteracts an otherwise 
deleterious coagulating effect of vWbp and coagulase in these patients. 
Apparently, S. aureus benefits from short-circuiting the host systems related to 
coagulation, otherwise receptins like vWbp, coagulase and SAK would not exist. 
Notably, both vWbp and coagulase have additional binding capacities, not 
required for coagulation, but perhaps still linked to coagulation, since both vWf 
and fibrinogen are of exceptional importance for hemostasis.  
 
A vWf-binding protein from S. lugdunensis (III) 
In some CoNS, e.g. S. epidermidis and S. haemolyticus, vWf-binding proteins 
have been reported (Li, Lundberg & Ljungh, 2000). A phage display library 
derived from another CoNS, S. lugdunensis, was panned against vWf. This 
resulted in the identification of a gene, present in the clinical strains tested, which 
encoded a vWf-binding protein of 2060 amino acids, termed vWbl (III).  
 
The hallmarks of a cell-surface receptin, an N-terminal signal peptide and a cell 
wall sorting signal, are present in the deduced sequence of vWbl. After the signal 
peptide follows an A-region of unknown function, encompassing approximately 
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two thirds of the protein. Next to the A-region follows a repeat (R)-region, 
comprising 10 imperfect repeats, R1-R10, each consisting of 67 amino acids. The 
signal peptide contains the motif YSIRK-G/S, demonstrated to aid efficient 
secretion (Bae & Schneewind, 2003). In the C-terminal part of the A-region, an 
RGD-motif is located. This motif is found in numerous host ECM-molecules and 
mediates integrin-binding (Ruoslahti & Pierschbacher, 1987). The R-region shows 
homology to repeats in a cell wall anchored protein associated with the virulence 
of Streptococcus suis (Smith et al., 1992; Vecht et al., 1991). The R-region of 
vWbl is also the vWf-binding region. From the panning experiments, a minimal 
binding region was mapped to 24 amino acids in the C-terminus of R2. Three 
separate panning experiments resulted in clones mapping to this repeat only, 
although nine of the ten repeats are 65% identical. In a fourth panning experiment, 
the elution condition was changed from lowering of the pH, to allowing infection 
of the bacteria directly. This resulted in inserts recovered also from R5. Some 
phagemid particles were evidently not released by lowering the pH, and possibly 
other repeats are recovered by other elution conditions.  
 
A phage stock prepared from a representative clone, was panned separately 
against several different immobilised ligands., Approximately 1000 to 10000 more 
phagemid particles bound to vWf than to any other ligands tested. A recombinant 
protein, corresponding to R1-R3 of vWbl, could inhibit this interaction, as could 
specific antibodies against vWbl, but not pre-immune antibodies. Also various 
ELISAs were performed, and the binding between recombinant vWbl and 
immobilised vWf could be specifically inhibited by soluble vWf. Thus, both 
soluble and immobilised vWf are recognised by vWbl. Interestingly, and a bit 
surprising, a recombinant peptide comprising the minimal binding domain of 
vWbp (I), inhibited interaction between vWbl and vWf in a dose-dependent 
manner.  
 
The minimal binding domains of both vWbp and vWbl are small and they show 
no apparent sequence similarities. It is intriguing that these pathogenic 
staphylococci both have evolved proteins that seem to bind to the same site in such 
a large protein. Since vWbp is secreted, the primary function is not to confer 
adhesion of S. aureus, but instead to exercise some influence on hemostasis, or 
maybe innate immunity, via interaction with vWf. However, vWbl is cell wall 
anchored, and probably acts as an adhesin. Theoretically, vWbl might also affect 
the function of vWf. Since vWf is the critical bridging molecule required for 
platelet adherence to exposed subendothelium, as well as platelet aggregation 
during arterial blood flow, vWbl and its interaction with vWf is interesting 
because S. lugdunensis is reported to cause aggressive cases of endocarditis. The 
RGD-motif found in vWbl implicates the possible adherence of S. lugdunensis 
directly to eukaryotic cells and platelets. Direct staphylococcal binding to integrins 
through an RGD-dependent mechanism has not been reported, but other 
microorganisms use this way of adherence to host cells (Isberg & Tran Van Nhieu, 
1994). However, indirect binding of S. aureus to integrins via fibronectin has been 
reported to result in the internalisation of staphylococci in non-professional 
phagocytic cells (Joh et al., 1999; Fowler et al., 2000). If an equal mechanism 
exists for S. lugdunensis remains to be investigated.    40
Sorting an S. aureus phage library against ex vivo biomaterial (IV)  
As discussed previously in this thesis, the use of biomaterials increases in modern 
medicine.  S. aureus is recognised as one of the most important pathogens of 
nosocomial bloodstream infections (Lowy, 1998). A major risk factor for being 
affected by this type of infection is having an intravascular devise, e.g. a central 
venous catheter (CVC) inserted. Various plasma proteins adsorb to a CVC present 
in the bloodstream, enabling S. aureus to adhere by means of cell surface 
associated receptins, thus initiating infection. To further investigate the receptins 
possibly involved in this adherence, an S. aureus phage display library was panned 
against a CVC removed from a patient two days after insertion (IV). 
  
The numbers of eluted phagemid particles, as well as the frequency of E-tag 
positive clones, increased in three consecutive cycles of panning, thus indicating 
an enrichment of correct clones. From each panning, the insert of ~50 E-tag 
positive clones were sequenced. Six different receptins were identified: coagulase, 
Efb, protein A, FnbpA and B, and Sbi. The majority of the isolated phagemid 
particles encoded the fibrinogen-binding part of coagulase, or the β2-GPI-binding 
part of protein Sbi. The library was also panned against plasma proteins coated for 
one hour in vitro. Of 24 E-tag positive clones isolated, no β2-GPI-binding 
phagemid particles were found, while fibrinogen-binding phagemid particles were 
dominating. Thus, fibrinogen is the main host protein recognised by S. aureus 
receptins after a short in vitro coating, whereas other host proteins like β2-GPI, 
possibly deposited later than fibrinogen, might be important in vivo.  
 
  To find out whether the high number of β2-GPI-binding phagemid particles 
isolated from the panning against the ex vivo CVC was the result of β2-GPI being a 
major host component on biomaterial, or perhaps just more accessible. CVCs 
removed from patients after various implantation times, between 6 and 18 days, 
were investigated. Western blot analysis were performed on proteins released from 
the ex vivo biomaterials, using antibodies against fibrinogen, fibronectin, IgG, and 
β2-GPI. Fibrinogen was found to be the major component on all CVCs, but 
fibronectin and β2-GPI were also detected on all tested biomaterials, whereas the 
presence of IgG varied among the CVCs. To our knowledge, the presence of 
β2-GPI on ex vivo biomaterials has not been demonstrated prior to this study. For 
bacterial adherence to biomaterial, the total amount of adsorbed host proteins is 
not as important as the surface-available components.  
 
To study the accessibility of fibrinogen, IgG, and β2-GPI on the different CVCs, 
three different phage stocks with these binding specificities were used. Several 
factors might affect the number of phage particles obtained after a panning 
experiment. However, it is conceivable that the accessibility of the ligand is the 
most important factor. Subsequently, the number of released phage particles in 
panning against ex vivo biomaterial should give an indication of the accessibility 
of the different proteins. The different phage stocks bound all CVCs, but not to an 
uncoated CVC. Thus these three host proteins were present on the surface of all 
ex vivo biomaterials tested. The number of phagemid particles binding to β2-GPI 
on the biomaterial was similar to those binding to fibrinogen. The number of 
phagemid particles binding to these proteins in pure form, results in ~50 times 
more phagemid particles binding to fibrinogen, than to β2-GPI. This means that   41
although, β2-GPI is present in much lower amounts than fibrinogen on the CVCs, 
the surface accessibility of β2-GPI might be higher. Taken together, our result 
suggests that fibrinogen is the protein most accessible at the surface after a short in 
vitro coating with plasma, but after a long in vivo coating the surface accessibility 
of other proteins like β2-GPI increases compared to fibrinogen. These data are in 
accordance with a previous study, which reported on the lower contribution of 
fibrinogen in S. aureus adherence, when fibrinogen was deposited on biomaterial 
during hemodialysis, compared to when pure fibrinogen was coated onto a 
hemodialysis tubing in vitro (Francois et al., 2000). In that study, the presence of 
an additional unidentified host component was suggested to be of importance for 
the adherence of S.  aureus to biomaterial. Thus, in view of our results, this 
component could be β2-GPI, which S. aureus can bind via protein Sbi. 
 
Affinity selection of an S. aureus phage display library against an ex vivo CVC 
revealed several interactions of supposed biological significance for S. aureus 
adherence to biomaterials. However, during panning, it is possible to identify 
protein interactions of high affinity, regardless of the localisation and function of 
the binding protein, i.e. to encounter a interaction without biological meaning. 
Also, it is not realistic that all hypothetically possible interactions are identified. 
Although the main selection factor of phagemid particles should be affinity and 
accessibility of the ligand, other factors might also influence which phagemid 
particles that are found after a panning. For example, various phagemid clones 
might replicate to different numbers, and also, non-identical polypeptides sharing 
the same binding specificity could be displayed with different efficiency. 
Consequently, some phagemid particles displaying certain domains will lose in the 
competition with other binding phagemid particles. 
 
Sorting an S. epidermidis phage library against ex vivo biomaterials 
CoNS are the bacteria most frequently isolated from biomaterial infections 
(von Eiff, et al., 2002). Of these, S. epidermidis is the most common pathogen 
isolated. Therefore, a library constructed from a clinical isolate of S. epidermidis 
was panned against different ex vivo biomaterials, e.g. CVCs, and screws removed 
from bone (Bjerketorp et al., unpublished). The most frequently isolated phagemid 
particles contained overlapping inserts of the gene encoding dihydrolipoamide 
acetyltransferase, an intracellular glycolytic protein of the pyruvate dehydrogenase 
complex. Further, phagemid particles encoding Fbe were found (Nilsson et al., 
1998). To investigate if the acetyltransferase might be a moonlighting protein, also 
located on the cell surface of S. epidermidis, antibodies against the protein were 
raised. Non-covalently bound surface proteins from the clinical strain were 
extracted, and analysed by Western blot. A protein of expected size was detected 
by the specific antibodies. The surface expression of the presumed 
acetyltransferase peaked during early exponential growth phase. The identity of 
the acetyltransferase interacting factor on the ex vivo biomaterials is unknown, as 
the biological importance of this interaction during infection.   42
Concluding remarks  
 
“Facts are the air of scientists. 
Without them you can never fly.”  
Linus Pauling  
 
In this thesis, interactions between bacterial proteins and host proteins have been 
studied, mainly using phage display. Panning an S. aureus phage display library 
against ex vivo biomaterial led to the identification of β2-GPI on the surface of 
CVCs. This is interesting in view of S. aureus adherence, but might also have 
significance in the induction of β2-GPI-autoantibodies found in the autoimmune 
disease called antiphospholipid syndrome. Two novel vWf-binding receptins have 
also been identified, one secreted from S. aureus, and one surface-anchored from 
S. lugdunensis. Further characterisation revealed vWbp to be a bifunctional 
protein capable of inducing coagulation of plasma from several species, with 
specific species tropism for human and porcine plasma. 
 
The coagulation system and innate immune response are merely different 
aspects of the overall host integrity scheme. Obviously, S. aureus must benefit 
from affecting some of the key events of this scheme to its own purpose, since S. 
aureus has evolved an large number of receptins recognising many different 
components in the host ECM, and of the coagulation system/innate immune 
response. A common feature of many S. aureus receptins is that they often possess 
multiple functions, some of which are unique, and some that instead overlap with 
the function of other receptins. Most likely, no single receptin is indispensable for 
the overall virulence of S. aureus, since other receptins can compensate the loss. 
Of special interest would be to construct an S. aureus deletion mutant lacking the 
genes encoding vWbp, coagulase and SAK. By complementing these receptins, in 
different combinations, and in an appropriate animal model, it should be possible 
to clarify this potentially important aspect of S. aureus virulence. However, the 
contribution of the interactions identified in this thesis to the pathogenesis of 
S. aureus and S. lugdunensis remains to be elucidated.  
 
As staphylococcal resistance against available antibiotics continues to increase, 
research efforts have to proceed to find novel functional treatments against these 
unrelenting opportunistic pathogens. A lot of future promise is seen in the 
exploration of antimicrobial peptides, used by organisms from insects to man as 
part of their innate immune system (Hancock, 2001). Apparently, microbes do not 
easily develop resistance against these peptides, but so far systemic use has been 
hampered, e.g. by unwanted side effects. All efforts to develop staphylococcal 
vaccines have so far met with limited success, and today it is hard to say which 
components that in the end will be included in a vaccine, that gives prolonged 
protection. Passive immunisation using different antibody preparations are 
currently being evaluated, to be used for certain groups at high risk of 
staphylococcal infection, e.g. premature infants (Hall et al., 2003; Vernachio et al., 
2003). The strategy of passive immunisation has historically been successful in 
some part of the world, even for the treatment of severe cases of staphylococcal infection caused by resistant S. aureus (Kelly, 2000). A total eradication of the 
commensal staphylococcal flora is not desirable, since this might result in the 
colonisation by even worse opportunistic pathogens. Possibly it might be feasible 
to replace virulent and resistant staphylococcal strains with avirulent strains in a 
probiotic manner. Regardless of the approach chosen to overcome the problem of 
bacterial resistance, man will benefit from gaining more knowledge about the 
individual virulence factors, the regulation of virulence genes, and about the 
ecological interplay between bacteria and host. 
 
 
 
 
 
 
 
 
 
 
 
 
 
  43  44
References 
 
Abdelnour, A., Arvidson, S., Bremell, T., Rydén, C., and Tarkowski, A. (1993) The 
accessory gene regulator (agr) controls Staphylococcus aureus virulence in a murine 
arthritis model. Infect Immun 61: 3879-3885. 
Allignet, J., Galdbart, J.O., Morvan, A., Dyke, K.G., Vaudaux, P., Aubert, S., Desplaces, 
N., and el Solh, N. (1999) Tracking adhesion factors in Staphylococcus caprae strains 
responsible for human bone infections following implantation of orthopaedic material. 
Microbiology 145: 2033-2042. 
Amagai, M., Matsuyoshi, N., Wang, Z.H., Andl, C., and Stanley, J.R. (2000) Toxin in 
bullous impetigo and staphylococcal scalded-skin syndrome targets desmoglein 1. Nat 
Med 6: 1275-1277. 
Amagai, M. (2003) Desmoglein as a target in autoimmunity and infection. J Am Acad 
Dermatol 48: 244-252. 
Anonymous (2002a) Staphylococcus aureus resistant to vancomycin--United States, 2002. 
MMWR Morb Mortal Wkly Rep 51: 565-567. 
Anonymous (2002b) Vancomycin-resistant Staphylococcus aureus--Pennsylvania, 2002. 
MMWR Morb Mortal Wkly Rep 51: 902. 
Anonymous (2003) National Nosocomial Infections Surveillance (NNIS) System Report, 
data summary from January 1992 through June 2003, issued August 2003. Am J Infect 
Control 31: 481-498. 
Arvidson, S. (2000) Extracellular ezymes. In Gram-positive pathogens. Eds. Fischetti, V., 
A. et al., pp. 379-385, ASM Press, Washington DC. 
Azzazy, H.M., and  Highsmith, W.E., Jr. (2002) Phage display technology: clinical 
applications and recent innovations. Clin Biochem 35: 425-445. 
Badylak, S.F. (2002) The extracellular matrix as a scaffold for tissue reconstruction. Semin 
Cell Dev Biol 13: 377-383. 
Bae, T., and  Schneewind, O. (2003) The YSIRK-G/S motif of staphylococcal protein A 
and its role in efficiency of signal peptide processing. J Bacteriol 185: 2910-2919. 
Bamberger, D.M., Bettin, K.M., and  Gerding, D.N. (1987) Neutrophil localization in acute 
and chronic experimental abscesses. J Lab Clin Med 109: 389-395. 
Bamberger, D.M., Herndon, B.L., Bettin, K.M., and Gerding, D.N. (1989) Neutrophil 
chemotaxis and adherence in vitro and localization in vivo in rabbits with Staphylococcus 
aureus abscesses. J Lab Clin Med 114: 135-141. 
Bamberger, D.M., and  Herndon, B.L. (1990) Bactericidal capacity of neutrophils in rabbits 
with experimental acute and chronic abscesses. J Infect Dis 162: 186-192. 
Bass, S., Greene, R., and  Wells, J.A. (1990) Hormone phage: an enrichment method for 
variant proteins with altered binding properties. Proteins 8: 309-314. 
Bodén, M.K., and  Flock, J.I. (1989) Fibrinogen-binding protein/clumping factor from 
Staphylococcus aureus. Infect Immun 57: 2358-2363. 
Butenas, S., and  Mann, K.G. (2002) Blood coagulation. Biochemistry (Mosc) 67: 3-12. 
Casadevall, A., and  Scharff, M.D. (1995) Return to the past: the case for antibody-based 
therapies in infectious diseases. Clin Infect Dis 21: 150-161. 
Chavakis, T., Hussain, M., Kanse, S.M., Peters, G., Bretzel, R.G., Flock, J.I., Herrmann, 
M., and Preissner, K.T. (2002) Staphylococcus aureus extracellular adherence protein 
serves as anti-inflammatory factor by inhibiting the recruitment of host leukocytes. Nat 
Med 8: 687-693. 
Clarke, S.R., Harris, L.G., Richards, R.G., and Foster, S.J. (2002) Analysis of Ebh, a 1.1-
megadalton cell wall-associated fibronectin-binding protein of Staphylococcus aureus. 
Infect Immun 70: 6680-6687. 
Clarke, S.R., Wiltshire, M.D., and  Foster, S.J. (2004) IsdA of Staphylococcus aureus is a 
broad spectrum, iron-regulated adhesin. Mol Microbiol 51: 1509-1519. 
Collen, D., and  Lijnen, H.R. (1991) Basic and clinical aspects of fibrinolysis and 
thrombolysis. Blood 78: 3114-3124.   45
Collen, D. (1998) Staphylokinase: a potent, uniquely fibrin-selective thrombolytic agent. 
Nat Med 4: 279-284. 
Costerton, J.W., Stewart, P.S., and  Greenberg, E.P. (1999) Bacterial biofilms: a common 
cause of persistent infections. Science 284: 1318-1322. 
Courtney, J.M., Lamba, N.M., Sundaram, S., and Forbes, C.D. (1994) Biomaterials for 
blood-contacting applications. Biomaterials 15: 737-744. 
Cucarella, C., Solano, C., Valle, J., Amorena, B., Lasa, I., and Penades, J.R. (2001) Bap, a 
Staphylococcus aureus surface protein involved in biofilm formation. J Bacteriol 183: 
2888-2896. 
Cucarella, C., Tormo, M.A., Knecht, E., Amorena, B., Lasa, I., Foster, T.J., and Penades, 
J.R. (2002) Expression of the biofilm-associated protein interferes with host protein 
receptors of Staphylococcus aureus and alters the infective process. Infect Immun 70: 
3180-3186. 
Dahlbäck, B. (2000) Blood coagulation. Lancet 355: 1627-1632. 
Davies, D. (2003) Understanding biofilm resistance to antibacterial agents. Nat Rev Drug 
Discov 2: 114-122. 
Davis, S.L., Gurusiddappa, S., McCrea, K.W., Perkins, S., and Höök, M. (2001) SdrG, a 
fibrinogen-binding bacterial adhesin of the microbial surface components recognizing 
adhesive matrix molecules subfamily from Staphylococcus epidermidis, targets the 
thrombin cleavage site in the Bbeta chain. J Biol Chem 276: 27799-27805. 
De Haas, C.J., Veldkamp, K.E., Peschel, A., Weerkamp, F., Van Wamel, W.J., Heezius, 
E.C., Poppelier, M.J., Van Kessel, K.P., and Van Strijp, J.A. (2004) Chemotaxis 
Inhibitory Protein of Staphylococcus aureus, a Bacterial Antiinflammatory Agent. J Exp 
Med 199: 687-695. 
Diekema, D.J., and  Jones, R.N. (2001) Oxazolidinone antibiotics. Lancet 358: 1975-1982. 
Dinges, M.M., Orwin, P.M., and  Schlievert, P.M. (2000) Exotoxins of Staphylococcus 
aureus. Clin Microbiol Rev 13: 16-34, table of contents. 
Dohlsten, M., Björklund, M., Sundstedt, A., Hedlund, G., Samson, D., and Kalland, T. 
(1993) Immunopharmacology of the superantigen staphylococcal enterotoxin A in T-cell 
receptor V beta 3 transgenic mice. Immunology 79: 520-527. 
Donlan, R.M. (2001) Biofilm formation: a clinically relevant microbiological process. Clin 
Infect Dis 33: 1387-1392. 
Doolittle, R.F. (2003) Structural basis of the fibrinogen-fibrin transformation: contributions 
from X-ray crystallography. Blood Rev 17: 33-41. 
Downer, R., Roche, F., Park, P.W., Mecham, R.P., and Foster, T.J. (2002) The elastin-
binding protein of Staphylococcus aureus (EbpS) is expressed at the cell surface as an 
integral membrane protein and not as a cell wall-associated protein. J Biol Chem 277: 
243-250. 
Dryla, A., Gelbmann, D., von Gabain, A., and Nagy, E. (2003) Identification of a novel 
iron regulated staphylococcal surface protein with haptoglobin-haemoglobin binding 
activity. Mol Microbiol 49: 37-53. 
Dufour, P., Jarraud, S., Vandenesch, F., Greenland, T., Novick, R.P., Bes, M., Etienne, J., 
and Lina, G. (2002) High genetic variability of the agr locus in Staphylococcus species. J 
Bacteriol 184: 1180-1186. 
Emori, T.G., and  Gaynes, R.P. (1993) An overview of nosocomial infections, including the 
role of the microbiology laboratory. Clin Microbiol Rev 6: 428-442. 
Etienne, J., Pangon, B., Leport, C., Wolff, M., Clair, B., Perronne, C., Brun, Y., and Bure, 
A. (1989) Staphylococcus lugdunensis endocarditis. Lancet 1: 390. 
Farrell, A.M. (1999) Staphylococcal scalded-skin syndrome. Lancet 354: 880-881. 
Fleurette, J., Bes, M., Brun, Y., Freney, J., Forey, F., Coulet, M., Reverdy, M.E., and 
Etienne, J. (1989) Clinical isolates of Staphylococcus lugdunensis and S. schleiferi: 
bacteriological characteristics and susceptibility to antimicrobial agents. Res Microbiol 
140: 107-118. 
Flock, J.I. (1999) Extracellular-matrix-binding proteins as targets for the prevention of 
Staphylococcus aureus infections. Mol Med Today 5: 532-537.   46
Flock, M., and  Flock, J.I. (2001) Rebinding of extracellular adherence protein Eap to 
Staphylococcus aureus can occur through a surface-bound neutral phosphatase. J 
Bacteriol 183: 3999-4003. 
Foster, S.J. (1993) Molecular analysis of three major wall-associated proteins of Bacillus 
subtilis 168: evidence for processing of the product of a gene encoding a 258 kDa 
precursor two-domain ligand-binding protein. Mol Microbiol 8: 299-310. 
Fowler, T., Wann, E.R., Joh, D., Johansson, S., Foster, T.J., and Höök, M. (2000) Cellular 
invasion by Staphylococcus aureus involves a fibronectin bridge between the bacterial 
fibronectin-binding MSCRAMMs and host cell beta1 integrins. Eur J Cell Biol 79: 672-
679. 
Francois, P., Schrenzel, J., Stoerman-Chopard, C., Favre, H., Herrmann, M., Foster, T.J., 
Lew, D.P., and Vaudaux, P. (2000) Identification of plasma proteins adsorbed on 
hemodialysis tubing that promote Staphylococcus aureus adhesion. J Lab Clin Med 135: 
32-42. 
Friedrich, R., Panizzi, P., Fuentes-Prior, P., Richter, K., Verhamme, I., Anderson, P.J., 
Kawabata, S., Huber, R., Bode, W., and Bock, P.E. (2003) Staphylocoagulase is a 
prototype for the mechanism of cofactor-induced zymogen activation. Nature 425: 535-
539. 
Gemmell, C.G., Goutcher, S.C., Reid, R., and Sturrock, R.D. (1997) Role of certain 
virulence factors in a murine model of Staphylococcus aureus arthritis. J Med Microbiol 
46: 208-213. 
Gillaspy, A.F., Hickmon, S.G., Skinner, R.A., Thomas, J.R., Nelson, C.L., and Smeltzer, 
M.S. (1995) Role of the accessory gene regulator (agr) in pathogenesis of staphylococcal 
osteomyelitis. Infect Immun 63: 3373-3380. 
Gladysheva, I.P., Turner, R.B., Sazonova, I.Y., Liu, L., and Reed, G.L. (2003) 
Coevolutionary patterns in plasminogen activation. Proc Natl Acad Sci U S A 100: 9168-
9172. 
Goerke, C., Campana, S., Bayer, M.G., Doring, G., Botzenhart, K., and Wolz, C. (2000) 
Direct quantitative transcript analysis of the agr regulon of Staphylococcus aureus during 
human infection in comparison to the expression profile in vitro. Infect Immun 68: 1304-
1311. 
Goerke, C., Fluckiger, U., Steinhuber, A., Zimmerli, W., and Wolz, C. (2001) Impact of the 
regulatory loci agr, sarA and sae of Staphylococcus aureus on the induction of alpha-
toxin during device-related infection resolved by direct quantitative transcript analysis. 
Mol Microbiol 40: 1439-1447. 
Guss, B., Eliasson, M., Olsson, A., Uhlén, M., Frej, A.K., Jornvall, H., Flock, J.I., and 
Lindberg, M. (1986) Structure of the IgG-binding regions of streptococcal protein G. 
Embo J 5: 1567-1575. 
Götz, F., Bannerman, T., and Schleifer, K.H. (2004) The genera Staphylococcus and 
Macrococcus. In The prokaryotes: An evolving electronic resource for the 
microbiological community. Eds., Dworkin, M. et al., 3
rd edition, release 3.16, 
Springer-Verlag, New York, http://link.springer-ny.com/link/service/books/10125/. 
Hacker, J., Blum-Oehler, G., Muhldorfer, I., and Tschape, H. (1997) Pathogenicity islands 
of virulent bacteria: structure, function and impact on microbial evolution. Mol Microbiol 
23: 1089-1097. 
Hall, A.E., Domanski, P.J., Patel, P.R., Vernachio, J.H., Syribeys, P.J., Gorovits, E.L., 
Johnson, M.A., Ross, J.M., Hutchins, J.T., and Patti, J.M. (2003) Characterization of a 
protective monoclonal antibody recognizing Staphylococcus aureus MSCRAMM protein 
clumping factor A. Infect Immun 71: 6864-6870. 
Hancock, R.E. (2001) Cationic peptides: effectors in innate immunity and novel 
antimicrobials. Lancet Infect Dis 1: 156-164. 
Harraghy, N., Hussain, M., Haggar, A., Chavakis, T., Sinha, B., Herrmann, M., and Flock, 
J.I. (2003) The adhesive and immunomodulating properties of the multifunctional 
Staphylococcus aureus protein Eap. Microbiology 149: 2701-2707. 
Hartford, O.M., Wann, E.R., Höök, M., and Foster, T.J. (2001) Identification of residues in 
the Staphylococcus aureus fibrinogen-binding MSCRAMM clumping factor A (ClfA) 
that are important for ligand binding. J Biol Chem 276: 2466-2473.   47
Hartleib, J., Kohler, N., Dickinson, R.B., Chhatwal, G.S., Sixma, J.J., Hartford, O.M., 
Foster, T.J., Peters, G., Kehrel, B.E., and Herrmann, M. (2000) Protein A is the von 
Willebrand factor binding protein on Staphylococcus aureus. Blood 96: 2149-2156. 
Heilmann, C., Hussain, M., Peters, G., and Götz, F. (1997) Evidence for autolysin-mediated 
primary attachment of Staphylococcus epidermidis to a polystyrene surface. Mol 
Microbiol 24: 1013-1024. 
Heilmann, C., Herrmann, M., Kehrel, B.E., and Peters, G. (2002) Platelet-binding domains 
in 2 fibrinogen-binding proteins of Staphylococcus aureus identified by phage display. J 
Infect Dis 186: 32-39. 
Heilmann, C., Thumm, G., Chhatwal, G.S., Hartleib, J., Uekotter, A., and Peters, G. (2003) 
Identification and characterization of a novel autolysin (Aae) with adhesive properties 
from Staphylococcus epidermidis. Microbiology 149: 2769-2778. 
Hell, W., Meyer, H.G., and  Gatermann, S.G. (1998) Cloning of aas, a gene encoding a 
Staphylococcus saprophyticus surface protein with adhesive and autolytic properties. Mol 
Microbiol 29: 871-881. 
Hemker, H.C., Bas, B.M., and  Muller, A.D. (1975) Activation of a pro-enzyme by a 
stoichiometric reaction with another protein. The reaction between prothrombin and 
staphylocoagulase. Biochim Biophys Acta 379: 180-188. 
Herrmann, M., Hartleib, J., Kehrel, B., Montgomery, R.R., Sixma, J.J., and Peters, G. 
(1997) Interaction of von Willebrand factor with Staphylococcus aureus. J Infect Dis 
176: 984-991. 
Herwaldt, L.A. (2003) Staphylococcus aureus nasal carriage and surgical-site infections. 
Surgery 134: S2-9. 
Hienz, S.A., Schennings, T., Heimdahl, A., and Flock, J.I. (1996) Collagen binding of 
Staphylococcus aureus is a virulence factor in experimental endocarditis. J Infect Dis 
174: 83-88. 
Hildén, P., Savolainen, K., Tyynela, J., Vuento, M., and Kuusela, P. (1996) Purification and 
characterisation of a plasmin-sensitive surface protein of Staphylococcus aureus. Eur J 
Biochem 236: 904-910. 
Hiramatsu, K., Aritaka, N., Hanaki, H., Kawasaki, S., Hosoda, Y., Hori, S., Fukuchi, Y., 
and Kobayashi, I. (1997) Dissemination in Japanese hospitals of strains of 
Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet 350: 1670-1673. 
Huesca, M., Peralta, R., Sauder, D.N., Simor, A.E., and McGavin, M.J. (2002) Adhesion 
and virulence properties of epidemic Canadian methicillin-resistant Staphylococcus 
aureus strain 1: identification of novel adhesion functions associated with plasmin-
sensitive surface protein. J Infect Dis 185: 1285-1296. 
Hussain, M., Herrmann, M., von Eiff, C., Perdreau-Remington, F., and Peters, G. (1997) A 
140-kilodalton extracellular protein is essential for the accumulation of Staphylococcus 
epidermidis strains on surfaces. Infect Immun 65: 519-524. 
Hussain, M., Becker, K., von Eiff, C., Schrenzel, J., Peters, G., and Herrmann, M. (2001) 
Identification and characterization of a novel 38.5-kilodalton cell surface protein of 
Staphylococcus aureus with extended-spectrum binding activity for extracellular matrix 
and plasma proteins. J Bacteriol 183: 6778-6786. 
Ikeda, Y., Handa, M., Kawano, K., Kamata, T., Murata, M., Araki, Y., Anbo, H., Kawai, 
Y., Watanabe, K., Itagaki, I., and et al. (1991) The role of von Willebrand factor and 
fibrinogen in platelet aggregation under varying shear stress. J Clin Invest 87: 1234-1240. 
Isberg, R.R., and  Tran Van Nhieu, G. (1994) Binding and internalization of 
microorganisms by integrin receptors. Trends Microbiol 2: 10-14. 
Ito, T., Katayama, Y., Asada, K., Mori, N., Tsutsumimoto, K., Tiensasitorn, C., and 
Hiramatsu, K. (2001) Structural comparison of three types of staphylococcal cassette 
chromosome mec integrated in the chromosome in methicillin-resistant Staphylococcus 
aureus. Antimicrob Agents Chemother 45: 1323-1336. 
Jacobsson, K., and  Frykberg, L. (1998) Gene VIII-based, phage-display vectors for 
selection against complex mixtures of ligands. Biotechniques 24: 294-301. 
Jacobsson, K., and  Frykberg, L. (2001) Shotgun phage display cloning. Comb Chem High 
Throughput Screen 4: 135-143.   48
Jacobsson, K., Rosander, A., Bjerketorp, J., and Frykberg, L. (2003) Shotgun Phage 
Display - Selection for Bacterial Receptins or other Exported Proteins. Biol Proced 
Online 5: 123-135. 
Jeffery, C.J. (1999) Moonlighting proteins. Trends Biochem Sci 24: 8-11. 
Ji, G., Beavis, R., and  Novick, R.P. (1997) Bacterial interference caused by autoinducing 
peptide variants. Science 276: 2027-2030. 
Jin, T., Bokarewa, M., McIntyre, L., Tarkowski, A., Corey, G.R., Reller, L.B., and Fowler, 
V.G., Jr. (2003) Fatal outcome of bacteraemic patients caused by infection with 
staphylokinase-deficient Staphylococcus aureus strains. J Med Microbiol 52: 919-923. 
Joh, D., Wann, E.R., Kreikemeyer, B., Speziale, P., and Höök, M. (1999) Role of 
fibronectin-binding MSCRAMMs in bacterial adherence and entry into mammalian cells. 
Matrix Biol 18: 211-223. 
Jonsson, I.M., Mazmanian, S.K., Schneewind, O., Verdrengh, M., Bremell, T., and 
Tarkowski, A. (2002) On the role of Staphylococcus aureus sortase and sortase-catalyzed 
surface protein anchoring in murine septic arthritis. J Infect Dis 185: 1417-1424. 
Jonsson, I.M., Mazmanian, S.K., Schneewind, O., Bremell, T., and Tarkowski, A. (2003) 
The role of Staphylococcus aureus sortase A and sortase B in murine arthritis. Microbes 
Infect 5: 775-780. 
Josefsson, E., McCrea, K.W., Ni Eidhin, D., O'Connell, D., Cox, J., Höök, M., and Foster, 
T.J. (1998) Three new members of the serine-aspartate repeat protein multigene family of 
Staphylococcus aureus. Microbiology 144: 3387-3395. 
Jönsson, K., Signäs, C., Müller, H.P., and Lindberg, M. (1991) Two different genes encode 
fibronectin binding proteins in Staphylococcus aureus. The complete nucleotide sequence 
and characterization of the second gene. Eur J Biochem 202: 1041-1048. 
Jönsson, K., McDevitt, D., McGavin, M.H., Patti, J.M., and Höök, M. (1995) 
Staphylococcus aureus expresses a major histocompatibility complex class II analog. J 
Biol Chem 270: 21457-21460. 
Kaabia, N., Scauarda, D., Lena, G., and Drancourt, M. (2002) Molecular identification of 
Staphylococcus lugdunensis in a patient with meningitis. J Clin Microbiol 40: 1824-1825. 
Kaufmann, S.H. (1999) Cell-mediated immunity: dealing a direct blow to pathogens. Curr 
Biol 9: R97-99. 
Kawabata, S., Morita, T., Iwanaga, S., and Igarashi, H. (1985) Enzymatic properties of 
staphylothrombin, an active molecular complex formed between staphylocoagulase and 
human prothrombin. J Biochem (Tokyo) 98: 1603-1614. 
Kessler, C.M., Nussbaum, E., and  Tuazon, C.U. (1991) Disseminated intravascular 
coagulation associated with Staphylococcus aureus septicemia is mediated by 
peptidoglycan-induced platelet aggregation. J Infect Dis 164: 101-107. 
Kloos, W.E., and  Bannerman, T.L. (1994) Update on clinical significance of coagulase-
negative staphylococci. Clin Microbiol Rev 7: 117-140. 
Kronvall, G., and  Jönsson, K. (1999) Receptins: a novel term for an expanding spectrum of 
natural and engineered microbial proteins with binding properties for mammalian 
proteins. J Mol Recognit 12: 38-44. 
Kuroda, M., Ohta, T., Uchiyama, I., Baba, T., Yuzawa, H., Kobayashi, I., Cui, L., Oguchi, 
A., Aoki, K., Nagai, Y., Lian, J., Ito, T., Kanamori, M., Matsumaru, H., Maruyama, A., 
Murakami, H., Hosoyama, A., Mizutani-Ui, Y., Takahashi, N.K., Sawano, T., Inoue, R., 
Kaito, C., Sekimizu, K., Hirakawa, H., Kuhara, S., Goto, S., Yabuzaki, J., Kanehisa, M., 
Yamashita, A., Oshima, K., Furuya, K., Yoshino, C., Shiba, T., Hattori, M., Ogasawara, 
N., Hayashi, H., and Hiramatsu, K. (2001) Whole genome sequencing of meticillin-
resistant Staphylococcus aureus. Lancet 357: 1225-1240. 
Lambe, D.W., Jr., Ferguson, K.P., Keplinger, J.L., Gemmell, C.G., and Kalbfleisch, J.H. 
(1990) Pathogenicity of Staphylococcus lugdunensis, Staphylococcus schleiferi, and three 
other coagulase-negative staphylococci in a mouse model and possible virulence factors. 
Can J Microbiol 36: 455-463. 
Lee, L.Y., Miyamoto, Y.J., McIntyre, B.W., Hook, M., McCrea, K.W., McDevitt, D., and 
Brown, E.L. (2002) The Staphylococcus aureus Map protein is an immunomodulator that 
interferes with T cell-mediated responses. J Clin Invest 110: 1461-1471.   49
Lentz, B.R. (2003) Exposure of platelet membrane phosphatidylserine regulates blood 
coagulation. Prog Lipid Res 42: 423-438. 
Levy, S.B. (2001) Antibiotic resistance: consequences of inaction. Clin Infect Dis 33: S124-
129. 
Li, D.Q., Lundberg, F., and  Ljungh, Å. (2000) Binding of von Willebrand factor by 
coagulase-negative staphylococci. J Med Microbiol 49: 217-225. 
Lowy, F.D. (1998) Staphylococcus aureus infections. N Engl J Med 339: 520-532. 
Luppens, S.B., Reij, M.W., van der Heijden, R.W., Rombouts, F.M., and Abee, T. (2002) 
Development of a standard test to assess the resistance of Staphylococcus aureus biofilm 
cells to disinfectants. Appl Environ Microbiol 68: 4194-4200. 
Lähteenmäki, K., Kuusela, P., and  Korhonen, T.K. (2000) Plasminogen activation in 
degradation and penetration of extracellular matrices and basement membranes by 
invasive bacteria. Methods 21: 125-132. 
Lähteenmäki, K., Kuusela, P., and  Korhonen, T.K. (2001) Bacterial plasminogen activators 
and receptors. FEMS Microbiol Rev 25: 531-552. 
Mahoney, M.G., Wang, Z., Rothenberger, K., Koch, P.J., Amagai, M., and Stanley, J.R. 
(1999) Explanations for the clinical and microscopic localization of lesions in pemphigus 
foliaceus and vulgaris. J Clin Invest 103: 461-468. 
Manganelli, R., and  van de Rijn, I. (1999) Characterization of emb, a gene encoding the 
major adhesin of Streptococcus defectivus. Infect Immun 67: 50-56. 
Matsui, H., Sugimoto, M., Mizuno, T., Tsuji, S., Miyata, S., Matsuda, M., and Yoshioka, A. 
(2002) Distinct and concerted functions of von Willebrand factor and fibrinogen in mural 
thrombus growth under high shear flow. Blood 100: 3604-3610. 
Matsuka, Y.V., Anderson, E.T., Milner-Fish, T., Ooi, P., and Baker, S. (2003) 
Staphylococcus aureus fibronectin-binding protein serves as a substrate for coagulation 
factor XIIIa: evidence for factor XIIIa-catalyzed covalent cross-linking to fibronectin and 
fibrin. Biochemistry 42: 14643-14652. 
Mattsson, E., Herwald, H., Björck, L., and Egesten, A. (2002) Peptidoglycan from 
Staphylococcus aureus induces tissue factor expression and procoagulant activity in 
human monocytes. Infect Immun 70: 3033-3039. 
Mazmanian, S.K., Liu, G., Ton-That, H., and Schneewind, O. (1999) Staphylococcus 
aureus sortase, an enzyme that anchors surface proteins to the cell wall. Science 285: 
760-763. 
Mazmanian, S.K., Liu, G., Jensen, E.R., Lenoy, E., and Schneewind, O. (2000) 
Staphylococcus aureus sortase mutants defective in the display of surface proteins and in 
the pathogenesis of animal infections. Proc Natl Acad Sci U S A 97: 5510-5515. 
Mazmanian, S.K., Ton-That, H., and  Schneewind, O. (2001) Sortase-catalysed anchoring 
of surface proteins to the cell wall of Staphylococcus aureus. Mol Microbiol 40: 1049-
1057. 
Mazmanian, S.K., Ton-That, H., Su, K., and Schneewind, O. (2002) An iron-regulated 
sortase anchors a class of surface protein during Staphylococcus aureus pathogenesis. 
Proc Natl Acad Sci U S A 99: 2293-2298. 
Mazmanian, S.K., Skaar, E.P., Gaspar, A.H., Humayun, M., Gornicki, P., Jelenska, J., 
Joachmiak, A., Missiakas, D.M., and Schneewind, O. (2003) Passage of heme-iron across 
the envelope of Staphylococcus aureus. Science 299: 906-909. 
McCormick, J.K., Yarwood, J.M., and  Schlievert, P.M. (2001) Toxic shock syndrome and 
bacterial superantigens: an update. Annu Rev Microbiol 55: 77-104. 
McCrea, K.W., Hartford, O., Davis, S., Eidhin, D.N., Lina, G., Speziale, P., Foster, T.J., 
and Höök, M. (2000) The serine-aspartate repeat (Sdr) protein family in Staphylococcus 
epidermidis. Microbiology 146: 1535-1546. 
McDevitt, D., Francois, P., Vaudaux, P., and Foster, T.J. (1994) Molecular characterization 
of the clumping factor (fibrinogen receptor) of Staphylococcus aureus. Mol Microbiol 11: 
237-248. 
McDevitt, D., Nanavaty, T., House-Pompeo, K., Bell, E., Turner, N., McIntire, L., Foster, 
T., and Höök, M. (1997) Characterization of the interaction between the Staphylococcus 
aureus clumping factor (ClfA) and fibrinogen. Eur J Biochem 247: 416-424.   50
Melish, M.E., Glasgow, L.A., and  Turner, M.D. (1972) The staphylococcal scalded-skin 
syndrome: isolation and partial characterization of the exfoliative toxin. J Infect Dis 125: 
129-140. 
Moreillon, P., Entenza, J.M., Francioli, P., McDevitt, D., Foster, T.J., Francois, P., and 
Vaudaux, P. (1995) Role of Staphylococcus aureus coagulase and clumping factor in 
pathogenesis of experimental endocarditis. Infect Immun 63: 4738-4743. 
Morfeldt, E., Janzon, L., Arvidson, S., and Löfdahl, S. (1988) Cloning of a chromosomal 
locus (exp) which regulates the expression of several exoprotein genes in Staphylococcus 
aureus. Mol Gen Genet 211: 435-440. 
Morrissey, J.A., Cockayne, A., Hammacott, J., Bishop, K., Denman-Johnson, A., Hill, P.J., 
and Williams, P. (2002) Conservation, surface exposure, and in vivo expression of the 
Frp family of iron-regulated cell wall proteins in Staphylococcus aureus. Infect Immun 
70: 2399-2407. 
Mölkänen, T., Tyynelä, J., Helin, J., Kalkkinen, N., and Kuusela, P. (2002) Enhanced 
activation of bound plasminogen on Staphylococcus aureus by staphylokinase. FEBS Lett 
517: 72-78. 
Nguyen, T., Ghebrehiwet, B., and  Peerschke, E.I. (2000) Staphylococcus aureus protein A 
recognizes platelet gC1qR/p33: a novel mechanism for staphylococcal interactions with 
platelets. Infect Immun 68: 2061-2068. 
Ni Eidhin, D., Perkins, S., Francois, P., Vaudaux, P., Höök, M., and Foster, T.J. (1998) 
Clumping factor B (ClfB), a new surface-located fibrinogen-binding adhesin of 
Staphylococcus aureus. Mol Microbiol 30: 245-257. 
Nilsson, M., Frykberg, L., Flock, J.I., Pei, L., Lindberg, M., and Guss, B. (1998) A 
fibrinogen-binding protein of Staphylococcus epidermidis. Infect Immun 66: 2666-2673. 
Nizet, V., Ohtake, T., Lauth, X., Trowbridge, J., Rudisill, J., Dorschner, R.A., 
Pestonjamasp, V., Piraino, J., Huttner, K., and Gallo, R.L. (2001) Innate antimicrobial 
peptide protects the skin from invasive bacterial infection. Nature 414: 454-457. 
Noble, W.C., Virani, Z., and  Cree, R.G. (1992) Co-transfer of vancomycin and other 
resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus. 
FEMS Microbiol Lett 72: 195-198. 
Novick, R.P. (2003) Autoinduction and signal transduction in the regulation of 
staphylococcal virulence. Mol Microbiol 48: 1429-1449. 
O'Brien, L., Kerrigan, S.W., Kaw, G., Hogan, M., Penades, J., Litt, D., Fitzgerald, D.J., 
Foster, T.J., and Cox, D. (2002a) Multiple mechanisms for the activation of human 
platelet aggregation by Staphylococcus aureus: roles for the clumping factors ClfA and 
ClfB, the serine-aspartate repeat protein SdrE and protein A. Mol Microbiol 44: 1033-
1044. 
O'Brien, L.M., Walsh, E.J., Massey, R.C., Peacock, S.J., and Foster, T.J. (2002b) 
Staphylococcus aureus clumping factor B (ClfB) promotes adherence to human type I 
cytokeratin 10: implications for nasal colonization. Cell Microbiol 4: 759-770. 
O'Riordan, K., and  Lee, J.C. (2004) Staphylococcus aureus capsular polysaccharides. Clin 
Microbiol Rev 17: 218-234. 
Otto, M., Echner, H., Voelter, W., and Götz, F. (2001) Pheromone cross-inhibition between 
Staphylococcus aureus and Staphylococcus epidermidis. Infect Immun 69: 1957-1960. 
Pallen, M.J., Lam, A.C., Antonio, M., and Dunbar, K. (2001) An embarrassment of sortases 
- a richness of substrates? Trends Microbiol 9: 97-102. 
Palma, M., Nozohoor, S., Schennings, T., Heimdahl, A., and Flock, J.I. (1996) Lack of the 
extracellular 19-kilodalton fibrinogen-binding protein from Staphylococcus aureus 
decreases virulence in experimental wound infection. Infect Immun 64: 5284-5289. 
Palma, M., Haggar, A., and  Flock, J.I. (1999) Adherence of Staphylococcus aureus is 
enhanced by an endogenous secreted protein with broad binding activity. J Bacteriol 181: 
2840-2845. 
Palma, M., Shannon, O., Quezada, H.C., Berg, A., and Flock, J.I. (2001) Extracellular 
fibrinogen-binding protein, Efb, from Staphylococcus aureus blocks platelet aggregation 
due to its binding to the alpha-chain. J Biol Chem 276: 31691-31697.   51
Pancholi, V., and  Fischetti, V.A. (1998) alpha-enolase, a novel strong plasmin(ogen) 
binding protein on the surface of pathogenic streptococci. J Biol Chem 273: 14503-
14515. 
Park, P.W., Rosenbloom, J., Abrams, W.R., and Mecham, R.P. (1996) Molecular cloning 
and expression of the gene for elastin-binding protein (ebpS) in Staphylococcus aureus. J 
Biol Chem 271: 15803-15809. 
Parkin, J., and  Cohen, B. (2001) An overview of the immune system. Lancet 357: 1777-
1789. 
Pasi, K., J. (1999) Hemostasis: Components and processes. In Hemostasis and thrombosis 
protocols. Eds. Perry, D., J., and Pasi, K., J., pp.3-25, Humana press, Totowa, New 
Jersey. 
Pasqualini, R., and  Ruoslahti, E. (1996) Organ targeting in vivo using phage display 
peptide libraries. Nature 380: 364-366. 
Patel, A.H., Nowlan, P., Weavers, E.D., and Foster, T. (1987) Virulence of protein A-
deficient and alpha-toxin-deficient mutants of Staphylococcus aureus isolated by allele 
replacement. Infect Immun 55: 3103-3110. 
Patti, J.M., Boles, J.O., and  Höök, M. (1993) Identification and biochemical 
characterization of the ligand binding domain of the collagen adhesin from 
Staphylococcus aureus. Biochemistry 32: 11428-11435. 
Patti, J.M., Allen, B.L., McGavin, M.J., and Höök, M. (1994) MSCRAMM-mediated 
adherence of microorganisms to host tissues. Annu Rev Microbiol 48: 585-617. 
Peng, H.L., Novick, R.P., Kreiswirth, B., Kornblum, J., and Schlievert, P. (1988) Cloning, 
characterization, and sequencing of an accessory gene regulator (agr) in Staphylococcus 
aureus. J Bacteriol 170: 4365-4372. 
Peschel, A., Jack, R.W., Otto, M., Collins, L.V., Staubitz, P., Nicholson, G., Kalbacher, H., 
Nieuwenhuizen, W.F., Jung, G., Tarkowski, A., van Kessel, K.P., and van Strijp, J.A. 
(2001) Staphylococcus aureus resistance to human defensins and evasion of neutrophil 
killing via the novel virulence factor MprF is based on modification of membrane lipids 
with l-lysine. J Exp Med 193: 1067-1076. 
Phonimdaeng, P., O'Reilly, M., Nowlan, P., Bramley, A.J., and Foster, T.J. (1990) The 
coagulase of Staphylococcus aureus 8325-4. Sequence analysis and virulence of site-
specific coagulase-deficient mutants. Mol Microbiol 4: 393-404. 
Ponnuraj, K., Bowden, M.G., Davis, S., Gurusiddappa, S., Moore, D., Choe, D., Xu, Y., 
Höök, M., and Narayana, S.V. (2003) A "dock, lock, and latch" structural model for a 
staphylococcal adhesin binding to fibrinogen. Cell 115: 217-228. 
Rago, J.V., Vath, G.M., Bohach, G.A., Ohlendorf, D.H., and Schlievert, P.M. (2000) 
Mutational analysis of the superantigen staphylococcal exfoliative toxin A (ETA). J 
Immunol 164: 2207-2213. 
Recsei, P., Kreiswirth, B., O'Reilly, M., Schlievert, P., Gruss, A., and Novick, R.P. (1986) 
Regulation of exoprotein gene expression in Staphylococcus aureus by agar. Mol Gen 
Genet 202: 58-61. 
Reichardt, L., F. (1999) Extracellular matrix molecules and their receptors. Introduction. 
In Guidebook to the extracellular matrix, anchor, and adhesion proteins. Eds. Kreis, T., 
and Vale, R., pp. 335-344, Oxford university press, New York. 
Rhem, M.N., Lech, E.M., Patti, J.M., McDevitt, D., Höök, M., Jones, D.B., and Wilhelmus, 
K.R. (2000) The collagen-binding adhesin is a virulence factor in Staphylococcus aureus 
keratitis. Infect Immun 68: 3776-3779. 
Rice, L.B. (2000) Bacterial monopolists: the bundling and dissemination of antimicrobial 
resistance genes in gram-positive bacteria. Clin Infect Dis 31: 762-769. 
Roche, F.M., Massey, R., Peacock, S.J., Day, N.P., Visai, L., Speziale, P., Lam, A., Pallen, 
M., and Foster, T.J. (2003) Characterization of novel LPXTG-containing proteins of 
Staphylococcus aureus identified from genome sequences. Microbiology 149: 643-654. 
Roche, F.M., Meehan, M., and  Foster, T.J. (2003) The Staphylococcus aureus surface 
protein SasG and its homologues promote bacterial adherence to human desquamated 
nasal epithelial cells. Microbiology 149: 2759-2767. 
Ruggeri, Z.M., Dent, J.A., and  Saldivar, E. (1999) Contribution of distinct adhesive 
interactions to platelet aggregation in flowing blood. Blood 94: 172-178.   52
Ruoslahti, E., and  Pierschbacher, M.D. (1987) New perspectives in cell adhesion: RGD 
and integrins. Science 238: 491-497. 
Rupp, M.E., and  Archer, G.L. (1994) Coagulase-negative staphylococci: pathogens 
associated with medical progress. Clin Infect Dis 19: 231-243; quiz 244-235. 
Russel, M., Linderoth, N.A., and  Sali, A. (1997) Filamentous phage assembly: variation on 
a protein export theme. Gene 192: 23-32. 
Savage, B., Saldivar, E., and  Ruggeri, Z.M. (1996) Initiation of platelet adhesion by arrest 
onto fibrinogen or translocation on von Willebrand factor. Cell 84: 289-297. 
Sawai, T., Tomono, K., Yanagihara, K., Yamamoto, Y., Kaku, M., Hirakata, Y., Koga, H., 
Tashiro, T., and Kohno, S. (1997) Role of coagulase in a murine model of hematogenous 
pulmonary infection induced by intravenous injection of Staphylococcus aureus 
enmeshed in agar beads. Infect Immun 65: 466-471. 
Sawicka-Grzelak, A., Szymanowska, A., Mlynarczyk, A., and Mlynarczyk, G. (1993) 
Production of staphylokinase and hemolysin by coagulase-negative staphylococcus. Med 
Dosw Mikrobiol 45: 7-10. 
Savolainen, K., Paulin, L., Westerlund-Wikström, B., Foster, T.J., Korhonen, T.K., and 
Kuusela, P. (2001) Expression of pls, a gene closely associated with the mecA gene of 
methicillin-resistant Staphylococcus aureus, prevents bacterial adhesion in vitro. Infect 
Immun 69: 3013-3020. 
Schachter, B. (2003) Slimy business--the biotechnology of biofilms. Nat Biotechnol 21: 
361-365. 
Schittek, B., Hipfel, R., Sauer, B., Bauer, J., Kalbacher, H., Stevanovic, S., Schirle, M., 
Schroeder, K., Blin, N., Meier, F., Rassner, G., and Garbe, C. (2001) Dermcidin: a novel 
human antibiotic peptide secreted by sweat glands. Nat Immunol 2: 1133-1137. 
Schneewind, O., Model, P., and  Fischetti, V.A. (1992) Sorting of protein A to the 
staphylococcal cell wall. Cell 70: 267-281. 
Schwalbe, R.S., Stapleton, J.T., and  Gilligan, P.H. (1987) Emergence of vancomycin 
resistance in coagulase-negative staphylococci. N Engl J Med 316: 927-931. 
Schwarz-Linek, U., Werner, J.M., Pickford, A.R., Gurusiddappa, S., Kim, J.H., Pilka, E.S., 
Briggs, J.A., Gough, T.S., Höök, M., Campbell, I.D., and Potts, J.R. (2003) Pathogenic 
bacteria attach to human fibronectin through a tandem beta-zipper. Nature 423: 177-181. 
Shi, T., Iverson, G.M., Qi, J.C., Cockerill, K.A., Linnik, M.D., Konecny, P., and Krilis, 
S.A. (2004) {beta}2-Glycoprotein I binds factor XI and inhibits its activation by 
thrombin and factor XIIa: Loss of inhibition by clipped {beta}2-glycoprotein I. Proc Natl 
Acad Sci U S A 101: 3939-3944. 
Signäs, C., Raucci, G., Jönsson, K., Lindgren, P.E., Anantharamaiah, G.M., Höök, M., and 
Lindberg, M. (1989) Nucleotide sequence of the gene for a fibronectin-binding protein 
from Staphylococcus aureus: use of this peptide sequence in the synthesis of biologically 
active peptides. Proc Natl Acad Sci U S A 86: 699-703. 
Sjursen, H. (1999) Staphylococcal septicemia, endocarditis and intracranial infections. 
In The ever present pathogen. Eds. Espersen, F., Hedström, S. Å., and Solberg, C., O., 
pp. 209-336, Rosell & Co, Göteborg, Sweden. 
Sjödahl, J. (1977) Repetitive sequences in protein A from Staphylococcus aureus. 
Arrangement of five regions within the protein, four being highly homologous and Fc-
binding. Eur J Biochem 73: 343-351. 
Smith, G.P. (1985) Filamentous fusion phage: novel expression vectors that display cloned 
antigens on the virion surface. Science 228: 1315-1317. 
Smith, G.P., and  Petrenko, V.A. (1997) Phage Display. Chem Rev 97: 391-410. 
Smith, H.E., Vecht, U., Gielkens, A.L., and Smits, M.A. (1992) Cloning and nucleotide 
sequence of the gene encoding the 136-kilodalton surface protein (muramidase-released 
protein) of Streptococcus suis type 2. Infect Immun 60: 2361-2367. 
Sompolinsky, D., Samra, Z., Karakawa, W.W., Vann, W.F., Schneerson, R., and Malik, Z. 
(1985) Encapsulation and capsular types in isolates of Staphylococcus aureus from 
different sources and relationship to phage types. J Clin Microbiol 22: 828-834. 
Steinberg, J.P., Clark, C.C., and  Hackman, B.O. (1996) Nosocomial and community-
acquired Staphylococcus aureus bacteremias from 1980 to 1993: impact of intravascular 
devices and methicillin resistance. Clin Infect Dis 23: 255-259.   53
Stenger, S., Rosat, J.P., Bloom, B.R., Krensky, A.M., and Modlin, R.L. (1999) Granulysin: 
a lethal weapon of cytolytic T cells. Immunol Today 20: 390-394. 
Stewart, P.S., and  Costerton, J.W. (2001) Antibiotic resistance of bacteria in biofilms. 
Lancet 358: 135-138. 
Sullam, P.M., Bayer, A.S., Foss, W.M., and Cheung, A.L. (1996) Diminished platelet 
binding in vitro by Staphylococcus aureus is associated with reduced virulence in a rabbit 
model of infective endocarditis. Infect Immun 64: 4915-4921. 
Tang, Y.Q., Yeaman, M.R., and  Selsted, M.E. (2002) Antimicrobial peptides from human 
platelets. Infect Immun 70: 6524-6533. 
Taylor, J.M., and  Heinrichs, D.E. (2002) Transferrin binding in Staphylococcus aureus: 
involvement of a cell wall-anchored protein. Mol Microbiol 43: 1603-1614. 
Tsiodras, S., Gold, H.S., Sakoulas, G., Eliopoulos, G.M., Wennersten, C., Venkataraman, 
L., Moellering, R.C., and Ferraro, M.J. (2001) Linezolid resistance in a clinical isolate of 
Staphylococcus aureus. Lancet 358: 207-208. 
Tung, H., Guss, B., Hellman, U., Persson, L., Rubin, K., and Rydén, C. (2000) A bone 
sialoprotein-binding protein from Staphylococcus aureus: a member of the 
staphylococcal Sdr family. Biochem J 345: 611-619. 
Uhlén, M., Guss, B., Nilsson, B., Gatenbeck, S., Philipson, L., and Lindberg, M. (1984) 
Complete sequence of the staphylococcal gene encoding protein A. A gene evolved 
through multiple duplications. J Biol Chem 259: 1695-1702. 
van der Mee-Marquet, N., Achard, A., Mereghetti, L., Danton, A., Minier, M., and Quentin, 
R. (2003) Staphylococcus lugdunensis infections: high frequency of inguinal area 
carriage. J Clin Microbiol 41: 1404-1409. 
VandenBergh, M.F., Yzerman, E.P., van Belkum, A., Boelens, H.A., Sijmons, M., and 
Verbrugh, H.A. (1999) Follow-up of Staphylococcus aureus nasal carriage after 8 years: 
redefining the persistent carrier state. J Clin Microbiol 37: 3133-3140. 
Vaudaux, P.E., Monzillo, V., Francois, P., Lew, D.P., Foster, T.J., and Berger-Bachi, B. 
(1998) Introduction of the mec element (methicillin resistance) into Staphylococcus 
aureus alters in vitro functional activities of fibrinogen and fibronectin adhesins. 
Antimicrob Agents Chemother 42: 564-570. 
Vecht, U., Wisselink, H.J., Jellema, M.L., and Smith, H.E. (1991) Identification of two 
proteins associated with virulence of Streptococcus suis type 2. Infect Immun 59: 3156-
3162. 
Vernachio, J., Bayer, A.S., Le, T., Chai, Y.L., Prater, B., Schneider, A., Ames, B., 
Syribeys, P., Robbins, J., and Patti, J.M. (2003) Anti-clumping factor A immunoglobulin 
reduces the duration of methicillin-resistant Staphylococcus aureus bacteremia in an 
experimental model of infective endocarditis. Antimicrob Agents Chemother 47: 3400-
3406. 
Williams, R.J., Henderson, B., Sharp, L.J., and Nair, S.P. (2002) Identification of a 
fibronectin-binding protein from Staphylococcus epidermidis.  Infect Immun 70: 6805-
6810. 
Vischer, U.M., and  de Moerloose, P. (1999) von Willebrand factor: from cell biology to 
the clinical management of von Willebrand's disease. Crit Rev Oncol Hematol 30: 93-
109. 
von Eiff, C., Peters, G., and  Heilmann, C. (2002) Pathogenesis of infections due to 
coagulase-negative staphylococci. Lancet Infect Dis 2: 677-685. 
von Heijne, G. (1986) A new method for predicting signal sequence cleavage sites. Nucleic 
Acids Res 14: 4683-4690. 
Vroman, L., Adams, A.L., Fischer, G.C., and Munoz, P.C. (1980) Interaction of high 
molecular weight kininogen, factor XII, and fibrinogen in plasma at interfaces. Blood 55: 
156-159. 
Yeaman, M.R., and  Bayer, A.S. (1999) Antimicrobial peptides from platelets. Drug Resist 
Updat 2: 116-126. 
Yousif, Y., Schiltz, E., Okada, K., Batsford, S., and Vogt, A. (1994) Staphylococcal neutral 
phosphatase. A highly cationic molecule with binding properties for immunoglobulin. 
Apmis 102: 891-900.   54
Zhang, L., Jacobsson, K., Vasi, J., Lindberg, M., and Frykberg, L. (1998) A second IgG-
binding protein in Staphylococcus aureus. Microbiology 144: 985-991. 
Zhang, L., Jacobsson, K., Ström, K., Lindberg, M., and Frykberg, L. (1999) Staphylococcus 
aureus expresses a cell surface protein that binds both IgG and beta2-glycoprotein I. 
Microbiology 145: 177-183. 
Zhang, Y.Q., Ren, S.X., Li, H.L., Wang, Y.X., Fu, G., Yang, J., Qin, Z.Q., Miao, Y.G., 
Wang, W.Y., Chen, R.S., Shen, Y., Chen, Z., Yuan, Z.H., Zhao, G.P., Qu, D., Danchin, 
A., and Wen, Y.M. (2003) Genome-based analysis of virulence genes in a non-biofilm-
forming  Staphylococcus epidermidis strain (ATCC 12228). Mol Microbiol 49: 1577-
1593. 
   55
Acknowledgements 
 
When I think back on the years at the Department of Microbiology, a lot of good memories 
come to me, and I realise that I’ve really learnt a lot. I would like to address my gratitude to 
all the people who have contributed to this pleasant time, and mostly I would like to thank: 
 
My supervisor Lars Frykberg, for the scientific enthusiasm shared, and for encouraging 
creative thinking, which always led to another exciting experiment. The barbeques and 
all-night games of springtime boules was excellent.  
 
My associate supervisor Karin Jacobsson, for bringing some valuable realism to the many 
scientific discussions, and for keeping the lab running smoothly, as well as all the excellent 
proofreading. The gifts for my son every now and then warmed my heart. 
 
My associate supervisor Bengt Guss, for the cheerful attitude even through rougher times, 
and for general generosity. I appreciated the company during the ASM meeting in Florida 
and the leisure time afterwards with your family.  
 
Martin Lindberg, for shared knowledge, and for all constructive criticism concerning my 
writing. I believe it has improved considerably as a consequence.  
 
Our collaboration partners, Jan-Ingmar Flock and Åsa Ljungh, for shared knowledge, 
bacterial strains, protein samples and biomaterials. 
 
My mentor Åke Danielsson for taking the time to give me valuable perspectives from the 
scientific world outside the university, and for shared interest in climbing. 
 
Christer Signäs, for helping me whenever the computer decided to be disobedient, and for 
the courses we have managed to coordinate in a satisfactory manner. 
 
Martin Nisson, for all the fun we have had in the lab, during post-dissertation farces, on the 
frisbee golf court and so on. I really enjoyed participating on the wedding feast.  
 
My roommate Anna Rosander, for all the pleasant times at work and time off, for sharing 
the anguish and joy of thesis writing, child raising and party preparation. 
 
My former roommate Nora Ausmees, for being a role model and a good friend, managing 
to do big microbiology and still come back just in time for the party. 
 
Åsa Karlström, for all the chats in the lab, and for trying to talk some sense into me about 
eating my meals in front of the computer during the writing of this thesis.  
 
Jonas Lannergård, for striving on with the research without ever complaining, a useful 
quality for your many future sessions of dye preparation. 
 
The former members of the Adhesion group: Hans Lindmark, for organizing Martins stag 
party; Lihong Zhang, for being polite and friendly; Joszef Vasi, for encouraging my interest 
in proteins; Azar Pooyan, for delicious cultural exchange.  
 
My postgraduate student fellows and others, for all the exhausting games of “innebandy” 
played, and for the blissful long-distance skating trips during work hours. 
 
The intrinsic staff at “Mikro”, for the all the invaluable help with this and that. 
 
My wife Lotta, for being the most wonderful person in my life, and for sharing the marvel 
of raising our cheerful and charming son Anton. 
 
All the other members of my family, including my wife’s family, for their endless genuine 
interest and caring support throughout the years. 
 
My good friends, for numerous festivities and refreshing outdoor activities, like mountain 
tours, mushroom picking, fishing and whatnot.   56
This investigation was supported by grant 24/98 from the Swedish Foundation for Strategic 
Research, Infection & Vaccinology Research Program and Biostapro AB. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
My contributions to the papers in this thesis have been as follows: 
 
I.  Involved in planning of the work. Performed the major part of the laboratory 
work, analysis of data and writing the paper. 
 
II.  Contributed in planning the study. Performed the major part of the laboratory 
work, analysis of data and writing the paper. 
 
III. Participated in planning. Performed a minor part of the laboratory work and 
analysis of data. Substantial part in writing the paper. 
 
IV. Planned a large part in of the project. Performed a major part of the laboratory 
work, analysis of data and writing the paper. 
 
 